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STRESZCZENIE 
WSTĘP 
Nanocząstki obecne w środowisku, zarówno pochodzenia naturalnego  
i antropogeniczne, mają wpływ na ludzkie zdrowie. Powszechne zastosowanie nanomateriałów 
w wielu gałęziach przemysłu skutkuje wzrastającą akumulacją nanocząstek w środowisku 
abiotycznym, oraz w tkankach organizmów żywych. Negatywnymi skutkami biologicznej 
aktywności nanocząstek wskazywanymi najczęściej są alergie, nowotwory, choroby układu 
naczyniowo-sercowego, zaburzenia w rozwoju embrionalnym, zaburzenia wzrostu, toksyczność 
względem układu immunologicznego, zaburzenia krzepnięcia krwi, toksyczność w barierze 
krew-mózg, choroby neurodegeneracyjne, oraz zapalne dróg oddechowych i choroby z nimi 
związane[1]. 
Reaktywne formy tlenu i reaktywne formy azotu są produkowane w komórkach 
w warunkach fizjologicznych, jako cząsteczki gwarantujące homeostazę wewnątrzkomórkową. 
Odgrywają one kluczową rolę w procesie transdukcji sygnałów wewnątrzkomórkowych. 
Istotnym czynnikiem powodującym toksyczny efekt nanocząsteczek jest stres 
oksydacyjny, definiowany jako zaburzenie w równowadze między produkcją reaktywnych form 
tlenu i obroną antyoksydacyjną. Stres oksydacyjny związany jest z zaburzeniami komórkowego 
metabolizmu takimi jak zaburzenia w funkcjonowaniu łańcucha oddechowego i/lub glikolizy, 
wobec czego, stężenie glukozy jest jednym z kluczowych czynników warunkujących homeostazę 
redoks. 
Zwiększenie ilości glukozy w środowisku zewnątrzkomórkowym powoduje zmianę 
metabolizmu energetycznego komórek z fosforylacji oksydacyjnej na glikolizę, co może 
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zwiększyć produkcję reaktywnych form tlenu w komórce. To zjawisko jest tłumaczone 
zwiększeniem wewnątrzkomórkowego stężenia jonów wapnia, co skutkuje rozpadem 
mitochondriów i prowadzi do apoptozy. Dane literaturowe uzyskane w badaniach na liniach 
komórkowych są zbieżne z doświadczeniami z udziałem pacjentów cierpiących na cukrzycę typu 
drugiego, u których wykryto znaczącą utratę komórek β tłumaczoną zahamowaniem czynności 
glukozo-6-fosfatazy[2]. Metabolizm energetyczny większości komórek prawidłowych,  
w warunkach fizjologicznych, jest uzależniony od fosforylacji oksydacyjnej natomiast 
metabolizm komórek nowotworowych bazuje głównie na glikolizie[3]. To zjawisko, nazywane 
efektem Warburga, jest formą adaptacji komórek nowotworowych rozwijających się  
w warunkach hipoksji. Ograniczenie funkcji mitochondriów sprzyja jednocześnie ograniczeniu 
apoptozy, co jest jednym z objawów transformacji nowotworowej komórek.  
Stres azotowy jest silnie powiązany ze stresem oksydacyjnym. Pierwotny rodnik azotowy 
– tlenek azotu jest syntezowany z udziałem argininy, tlenu i NADPH przez syntazy tlenku azotu. 
Mimo krótkiego czasu półtrwania, wynoszącego kilka milisekund, cząsteczki tlenku azotu 
dyfundują bez przeszkód przez błony biologiczne, dzięki czemu są jednymi  
z kluczowych, autokrynnych i parakrynnych cząsteczek sygnałowych u kręgowców. 
Uniwersalność tlenku azotu jako cząsteczki sygnałowej, warunkuje jej udział w procesach na 
poziomie organizmalnym, takich jak regulacja napięcia mięśni gładkich naczyń krwionośnych  
i odpowiedź immunologiczna, oraz na poziomie narządów i komórek. W przypadku wątroby 
niewielkie stężenie tlenku azotu ma na celu utrzymanie homeostazy oraz zapobieganie stanom 
patologicznym. Jest ono warunkowane ekspresją konstytutywnej syntazy tlenku azotu. 
Natomiast indukowalna syntaza tlenku azotu ulega ekspresji w zaburzeniach funkcjonowania 
komórek wątroby[4]. Tlenek azotu jest cząsteczką o ograniczonej reaktywności, która w reakcji 
z anionorodnikiem ponadtlenkowym tworzy nadtlenoazotyn. Nadtlenoazotyn jest z kolei 
efektywnym utleniaczem i czynnikiem nitrującym, którego obecność w komórce skutkuje 
obniżeniem stężenia wewnątrzkomórkowych antyoksydantów oraz uszkodzeniami białek, 
lipidów i kwasów nukleinowych. 
Stres oksydacyjny jest zjawiskiem o dużym znaczeniu dla utrzymania homeostazy 
wewnątrzkomórkowej. Jest to związane nie tylko z potencjalnymi uszkodzeniami oksydacyjnymi 
cząsteczek budujących komórkę, ale również z rolą regulacyjną jaką pełnią wolne rodniki i inne 
reaktywne formy tlenu. Kluczowe szlaki przekaźnictwa wewnątrzkomórkowego mogą być 
regulowane przez status redoks komórek, jak również może dochodzić do bezpośredniej 
aktywacji czynników transkrypcyjnych pod wpływem reaktywnych form tlenu. Aktywacja 
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czynników transkrypcyjnych będzie w końcowym efekcie prowadziła do zmian w profilu 
ekspresyjnym genów i powstawania nowych białek. Dobrze udokumentowanym przykładem 
aktywacji czynnika transkrypcyjnego bezpośrednio przez status redoks jest aktywacja czynnika 
Nrf2, który ma zdolność do aktywacji genów, które w sekwencji promotorowej zawierają 
element ARE, a także genów dla białek odpowiedzialnych za detoksykację, np. transferaz 
glutationowych. Wiele białek z nadrodziny ABC jest pod kontrolą czynników transkrypcyjnych 
zależnych od statusu redoks. Zaburzenia ekspresji transporterów ABC mogą mieć znaczenie dla 
prawidłowego funkcjonowania komórki. W przypadku wystąpienia procesów chorobowych, 
takich jak nowotworzenie, mogą mieć znaczenie dla powodzenia stosowanego leczenia. 
CELE PRACY 
1. Ocena endogennej produkcji reaktywnych form tlenu zależnej od aktywności 
łańcucha oddechowego, jako czynnika modulującego toksyczność nanocząstek 
srebra.  
2. Rozstrzygnięcie roli stresu azotowego w toksyczności nanocząstek srebra. 
3. Ocena roli generowanych pod wpływem nanocząstek wolnych rodników tlenowych 
w procesie modulacji profilu mRNA dla wybranych białek ABC w dojrzałych 
dopaminergicznych neuronach oraz neuronach niezróżnicowanych. 
METODY 
Do realizacji celów rozprawy wykorzystano dwa komórkowe modele badawcze. 
Korzystano z linii HepG2 (linia wyprowadzona z raka wątrobowokomórkowego), oraz LUHMES 
(linia komórkowa wywodząca się ze śródmózgowia 8-tygodniowego płodu). Komórki linii HepG2 
hodowano w medium DMEM w dwóch wariantach stężenia glukozy. Niższe stężenie (5,5 
mmol/dm3) odpowiadało warunkom fizjologicznym, natomiast stężenie 25 mmol/dm3 jest 
zbieżne ze stężeniem wykrywanym podczas ostrego epizodu hiperglikemii. Linia LUHMES 
stanowi model neuronów dla komórek dzielących się, a po różnicowaniu służy jako model 
dojrzałych dopaminergicznych neuronów. Różnicowanie komórek LUHMES w dojrzałe 
dopaminergiczne neurony przeprowadzono zgodnie z procedurą opublikowaną w pracy 
Stępkowski T i wsp., 2016[5]. Obie linie komórkowe zostały zakupione z kolekcji ATCC (American 
Type Culture Collection). Hodowle komórkowe prowadzono zgodnie z zaleceniami. Jako 
czynniki inicjujący odpowiedź biologiczną modeli badawczych wykorzystano nanocząstki srebra 
o średnicy nominalnej 20 nm. Ocenę przeżywalności przeprowadzono w oparciu test akumulacji 
czerwieni obojętnej w lizosomach komórek żywych. Pomiary wewnątrzkomórkowej produkcji 
anionorodnika ponadtlenkowego w mitochondriach i cytoplazmie, nadtlenku wodoru oraz 
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tlenku azotu wykonano przy użyciu cytometrii przepływowej w oparciu o fluorescencję 
specyficznych sond. Pomiary produkcji mitochondrialnego nadtlenku wodoru wykonano  
z użyciem białka reporterowego HyPer-mito i cytometrii przepływowej. 
Izolacja kwasów nukleinowych została przeprowadzona za pomocą urządzenia MagNA 
Pure LC 2.0 (HepG2) oraz z użyciem odczynnika TRI (LUHMES). Reakcje odwrotnej transkrypcji 
przeprowadzono z użyciem SuperScript™ III First-Strand Synthesis SuperMiX. Ekspresja genów 
na poziomie mRNA związanych ze stresem oksydacyjnym była badana z użyciem komercyjnie 
dostępnego zestawu starterów (HOSL-1 – The human oxidative stress library). Ekspresja genów 
na poziomie mRNA dla białek z rodziny ABC została oceniona z użyciem komercyjnie dostępnego 
zestawu starterów (Roche). Stężenie nitrotyrozyny zostało oznaczone za pomocą komercyjnie 
dostępnego zestawu immunochemicznego ELISA (Merck Milipore), natomiast poziom nitracji 
tyrozyny w układzie bezkomórkowym został zbadany przez pomiar intensywności fluorescencji 
nitrotyrozyny. Aktywność enzymów antyoksydacyjnych została wyznaczona poprzez pomiar 
szybkości zmian w stężeniu odpowiednich substratów klasycznymi metodami 
absorpcjometrycznymi. 
WYNIKI 
Badania przedstawione w ramach rozprawy zawarte są w trzech powiązanych 
tematycznie pracach. W pracach Glucose availability determines silver nanoparticles toxicity in 
HepG2 oraz Silver nanoparticles can attenuate nitrative stress stwierdzono, że zmiana stężenia 
dostępnej glukozy w medium hodowlanym skutkowała ustaleniem nowej równowagi redoks. 
Stabilny status redoks, komórki uzyskiwały po 72 godzinach od momentu zmiany stężenia 
czynnika modulującego aktywność mitochondriów (glukozy). Ocenie poddano aktywność 
enzymów związanych z obroną antyoksydacyjną w komórkach hodowanych w medium 
suplementowanym różnymi stężeniami glukozy. Proces adaptacji komórek do obniżonego 
stężenia glukozy w środowisku spowodował wzrost znaczenia fosforylacji oksydacyjnej  
w energetycznym metabolizmie komórek. Obserwowany wzrost aktywności katalazy,  
S-transferazy glutationowej, dysmutazy ponadtlenkowej i reduktazy glutationowej świadczy  
o procesie adaptacji komórek do nowego stanu równowagi redoks. Zbadany został profil 
ekspresji genów związanych z obroną antyoksydacyjną w komórkach hodowanych na niższym 
stężeniu glukozy w stosunku do poziomu kontrolnego. Proces adaptacyjny komórek linii HepG2 
został potwierdzony przez analizę transkryptomu odpowiedzialnego głównie za odpowiedź 
komórki na stres oksydacyjny. Zwiększonej ekspresji uległy geny NOS2, GSTM5, ALB, MBL2, 
SCARA3 i CAT. Jednocześnie zaobserwowano obniżenie ekspresji genów związanych  
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z metabolizmem glutationu (GSS, GSTZ1, GSTA4, GPX), co sugeruje, że detoksykacja 
reaktywnych form tlenu produkowanych w następstwie obniżenia stężenia glukozy zachodzi na 
drodze szybkich, enzymatycznych reakcji, a nie z udziałem drobnocząsteczkowych 
antyoksydantów. Ponadto, stopniowe i chroniczne obniżenie stężenia glutationu aktywuje szlak 
przekaźnictwa NFκB, co kieruje metabolizm komórki na drogę indukcji mechanizmów 
antyoksydacyjnych. 
Obserwacje te pozwoliły zaproponować mechanizm, który decydował o różnicach  
w przeżywalności komórek HepG2 pod działaniem nanocząstek srebra w zależności  
od zawartości glukozy w medium hodowlanym. 
Stężenie glukozy w medium hodowlanym jest czynnikiem modulującym toksyczność 
nanocząstek srebra. Mechanizm tego zjawiska polega na stymulacji zdolności obrony 
antyoksydacyjnej komórek hodowanych w medium o obniżonym stężeniu glukozy przez 
intensyfikację fosforylacji oksydacyjnej związaną ze zwiększoną produkcją reaktywnych form 
tlenu. Śmierć 10 % komórek w hodowli prowadzonej z użyciem stężenia glukozy standardowo 
używanego w hodowli komórek HepG2 (25 mmol/dm3) wywołały nanocząstki srebra  
w stężeniu 1,4 raza niższym niż w przypadku hodowli utrzymywanej na medium o obniżonym 
poziomie glukozy (5,5 mmol/dm3) przez 24 godziny i 7,6 raza niższym niż w przypadku komórek 
hodowanych w medium o obniżonym poziomie glukozy przez miesiąc i dłużej. 
Oceniono produkcję nadtlenku wodoru w mitochondriach oraz produkcję reaktywnych 
form tlenu i azotu w komórkach HepG2 hodowanych w medium suplementowanym różnymi 
stężeniami glukozy w obecności nanocząstek srebra. 
Zaobserwowano, że nanocząstki srebra wywołują stres oksydacyjny w komórkach HepG2, 
objawiający się, zwiększeniem stężenia H2O2 w mitochondriach o 18 % w stosunku do komórek 
kontrolnych. Hodowla komórek w medium o obniżonym stężeniu glukozy umożliwiła adaptację 
komórek do warunków podwyższonego stresu oksydacyjnego dzięki zwiększonej aktywności 
mitochondrialnego łańcucha transportu elektronów, wobec czego nie zaobserwowano 
podwyższonego poziomu H2O2 po dodaniu do komórek nanocząstek srebra. 
Obniżenie stężenia glukozy w medium hodowlanym spowodowało spadek wykrywanych 
ilości rodnika ponadtlenkowego na poziomie komórkowym i mitochondrialnym, oraz obniżenie 
poziomu nadtlenków wewnątrzkomórkowych. Nanocząstki srebra spowodowały wzrost 
poziomu mitochondrialnego anionorodnika ponadtlenkowego oraz nadtlenków  
w komórkach hodowanych na medium o wyższym stężeniu glukozy. Poziom badanych 
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reaktywnych formy tlenu nie uległ zmianie pod wpływem nanocząstek srebra w komórkach 
hodowanych z użyciem medium o niższym stężeniu glukozy. 
Aby ocenić czy nanocząstki srebra modulują nitrację tyrozyny w układzie bezkomórkowym 
wykonano doświadczenia in vitro. Wykazano, że nanocząstki srebra obniżają poziom nitracji 
tyrozyny, najprawdopodobniej przez przyspieszanie rozkładu nadtlenoazotynu. 
Zweryfikowano hipotezę o roli reaktywnych form azotu i produktów stresu azotowego 
poprzez ocenę stężenia nitrotyrozyny w komórkach HepG2 hodowanych w mediach o różnym 
stężeniu glukozy, w obecności nanocząstek srebra. 
Stwierdzono, że endogenny poziom nitrotyrozyny w komórkach HepG2 był poza zasięgiem 
detekcji zestawu ELISA użytego w doświadczeniach. Nitracja białek wywołana egzogennym 
nadtlenoazotynem osiągnęła wyższy poziom w komórkach hodowanych w medium o 
obniżonym stężeniu glukozy. Nitrotyrozyna była szybciej usuwana w komórkach hodowanych 
w medium o wyższym stężeniu glukozy, co jest związane z większą aktywnością proteasomu. 
Podobny efekt zaobserwowano w komórkach hodowanych w medium o niższym stężeniu 
glukozy poddanych działaniu nanocząstek srebra, które na drodze szlaku przeźnictwa sygnałów 
NRF2 również powodują wzrost aktywności proteasomu. 
W wyżej wymienionych pracach wykazaliśmy, że toksyczność nanocząstek srebra jest silnie 
zależna od statusu redoks komórek, który jest konsekwencją aktywności łańcucha 
mitochondrialnego. Pozwoliło, to na postawienie tezy, że komórki których metabolizm silnie 
zależy od glikolizy są bardziej podatne na uszkodzenia wywołane działaniem nanocząstek 
srebra. Przykładem takich komórek są komórki neuronalne. Celem dalszych doświadczeń była 
ocena w jaki sposób stres oksydacyjny wywołany przez nanocząstki srebra może wpływać na 
profil mRNA genów kodujących białka z rodziny ABC. Białka z nadrodziny ABC są bardzo istotne 
dla prawidłowego funkcjonowania neuronów, warunkując równowagę lipidową w komórkach 
neuronalnych. Zmiana poziomu tych białek jest wiązana z procesem różnicowania oraz 
prawidłowym funkcjonowaniem przekaźnictwa wewnątrzkomórkowego. 
W pracy Exposure of human neurons to silver nanoparticles induces similar pattern of ABC 
transporters gene expression as differentiation: Study on proliferating and post-mitotic LUHMES 
cells największe zmiany w transkryptomie badanych genów zaobserwowano dla genów  
z rodziny ABCA, między innymi dla genu ABCA1. Zapostulowano mechanizm, w którym 
internalizacja fragmentów błony bogatych w cholesterol towarzysząca endocytozie 
nanocząstek srebra, zwiększa pulę cholesterolu w komórce dostępnego dla reaktywnych form 
tlenu. Oksysterole będące efektem utleniania cholesterolu są czynnikiem aktywującym czynnik 
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transkrypcyjny LXR, który warunkuje homeostazę cholesterolową w mózgu oraz wpływa na 
zwiększenie ekspresji białka ABCA1. 
Stwierdzono, że komórki intensywnie proliferujące poddane działaniu nanocząstek srebra 
wykazują profil ekspresji mRNA dla białek ABC analogiczny do tego, który związany jest  
z procesem różnicowania się w dojrzałe neurony dopaminergiczne. Świadczyć to może o tym, 
że stres wywołany przez nanocząstki w komórkach proliferujących może powodować 
zaburzenia różnicowania w płodowych komórkach neuronalnych. 
WNIOSKI 
1. Dostępność glukozy moduluje toksyczność nanocząstek srebra. Jest to związane  
z uaktywnieniem mechanizmów obrony antyoksydacyjnej przez wzmożoną aktywność 
łańcucha mitochondrialnego i co za tym idzie zwiększoną produkcję reaktywnych form 
tlenu. 
2. Typy komórek silnie zależne od glikolizy są bardziej podatne na toksyczny efekt 
nanomateriałów indukujących stres oksydacyjny.  
3. Nanocząstki srebra nie wywołują stresu azotowego, ale wpływają na potranslacyjne 
modyfikacje białek pośrednio, przez wpływ na ekspresję białek związanych z obroną 
przed stresem nitracyjnym. 
4. Prekursorowe komórki neuronalne są bardziej podatne na zmiany w ekspresji genów dla 
białek ABC wywołane przez nanocząstki srebra niż zróżnicowane neurony 
dopaminergiczne. 
5. Proces różnicowania neuronów powoduje podobny profil zmian w ekspresji genów dla 
białek ABC jak aktywność biologiczna nanocząstek srebra. 
6. Nanocząstki srebra aktywują czynnik transkrypcyjny LXR, co skutkuję zwiększoną 
ekspresją genu ABCA1 i możliwymi zaburzeniami w homeostacie cholesterolu. 
  
 11 
 
SUMMARY 
INTRODUCTION 
Nanoparticles present in the environment, both natural and anthropogenic, have  
a significant impact on human health. Wide range of nanomaterial application in various 
branches of industry results in their increasing accumulation in abiotic environment and in 
tissues of living organisms. Most often mentioned negative effects of nanoparticles biological 
activity are: inflammation of the respiratory tract and respiratory diseases, allergies, cancer, 
cardiovascular diseases, developmental toxicity, immune toxicity, toxicity to organs, 
thrombosis, toxicity in the blood-brain barrier and neurodegenerative diseases[1]. 
Both, reactive oxygen species and reactive nitrogen species are produced in cells as an 
important element of cellular physiology. They play a crucial regulatory role due to their 
involvement in intracellular signal transduction. 
Oxidative stress is an important factor in producing undesirable effects by nanoparticles. 
Oxidative stress is defined as a disturbance in the balance between the production of reactive 
oxygen species and antioxidant defenses or, more recently, as disruption of redox signaling and 
control. Occurrence of the oxidative stress is often associated with disturbances in metabolic 
processes, such as deregulation of mitochondrial respiratory chain and/or glycolysis. 
Especially, concentration of glucose has a significant effect on cellular metabolism, as 
increased glucose level results in switching of cells metabolism from oxidative phosphorylation 
(OXPHOS) to glycolysis in various cell types, that in turn increases ROS production. A proposed 
mechanism for this phenomenon involves an increase in intracellular calcium concentration 
resulting in mitochondrial fission through the function of dynamin-like protein 1, that leads to 
apoptosis. Results of in vitro studies on the link between increased glucose concentration and 
inhibition of cell proliferation in the model cell lines correlate with in vivo results. In patients 
with type 2 diabetes a massive loss of beta-cells is observed, which is associated with oxidative 
stress induced by inhibition of glucose-6-phosphatase[2]. In physiological conditions majority 
of normal cells rely on OXPHOS, whereas cancer cells metabolism is based mostly on glycolysis 
(so-called Warburg effect)[3]. The Warburg effect may be an adaptation to the limited oxygen 
supply, as an early development of cancer cells usually takes place in hypoxic environment of 
the growing tumor that has limited blood supply until its own vasculature is developed. Limiting 
the function of mitochondria can also promote the reduction of apoptotic process probability, 
which is one of the symptoms of carcinogenesis.  
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The primordial nitrogen radical – nitric oxide is synthesized from arginine, oxygen and 
NADPH by nitric oxide synthases. Despite the short half-life of a few milliseconds, nitric oxide 
molecules diffuse freely through the biological membranes, which makes them one of the 
crucial, both autocrine and paracrine, signaling molecules in vertebrates. The universality of 
nitric oxide as an intermittent signal molecule determines its participation in many processes 
at the organismal level, such as the regulation of the smooth muscle tone in the blood vessels 
and contribution in the process of immune response. In the liver, a small concentration of nitric 
oxide is key factor in maintaining homeostasis and prevention of pathologies. The structural 
concentration of nitric oxide is maintained in the course of activity of constitutive nitric oxide 
synthase. In contrast, the inducible nitric oxide synthase is expressed in liver cells of disturbed 
functions[4]. Nitrative stress is strongly connected to oxidative stress. Primal nitrogen radical – 
nitric oxide, is a particle of mild reactivity. However, its reaction with superoxide anion 
produces, peroxynitrite a molecule effective as oxidant and nitrating agent. Peroxynitrite, due 
to its aforementioned properties depletes cellular antioxidants and damages proteins, lipids 
and nucleic acids. 
Oxidative stress is a phenomenon of great importance for maintaining intracellular 
homeostasis. This is not only connected with potential oxidative damage of cell-building 
molecules, but also to the regulatory role played by free radicals and other reactive oxygen 
species. The key pathways of intracellular signal transmission can be regulated by the redox 
status of the cell, as well as through direct activation of transcription factors by reactive oxygen 
species. The activation of transcription factors will ultimately lead to changes in the gene 
expression profile. A well-documented example of activating a transcription factor directly 
through the redox status is activation of Nrf2 which has the ability to activate genes that contain 
the ARE element in the promoter sequence as well as genes coding for proteins responsible for 
the detoxification, such as GST. Many of the proteins from the ABC superfamily are under 
control of transcription factors dependent on the redox status. Disorders in the expression of 
ABC transporters can be important for the proper functioning of cells and may be important in 
the course of treatment of cancers. 
In course of my research I focused on silver nanoparticles-induced oxidative and 
nitrative stress, with special attention devoted to mitochondria. The aim of this study was to 
extend the knowledge in the aspect of mechanism of action of nanoparticles on the cellular 
level.  
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AIMS 
1. Evaluation of endogenous production of reactive oxygen species dependent on the 
activity of the respiratory chain, as a factor modulating toxicity of silver nanoparticles. 
2. Resolving the role of nitrogen stress in the toxicity of silver nanoparticles. 
3. Evaluation of the role of oxygen free radicals generated under the influence of 
nanoparticles in the process of modulation of mRNA profile for selected ABC proteins in 
mature dopaminergic neurons and undifferentiated neurons. 
METHODS 
 Two cell lines were used as research models to achieve the goals of this dissertation: 
HepG2 cell line – derived from hepatocellular carcinoma and LUHMES cell line – derived from 
the midbrain of 8-week fetus. HepG2 cells were grown in DMEM medium in two variants of 
glucose concentration. The lower concentration (5.5 mmol / dm3) corresponded to the 
physiological conditions, whereas the concentration of 25 mmol / dm3 is convergent with the 
concentration in acute diabetic shock. The LUHMES cell line is a model of dividing and mature 
dopaminergic neurons. Differentiation of LUHMES cells into mature dopaminergic neurons was 
performed according to work of Stepkowski et al [5]. Both cell lines were purchased from ATCC 
(American Type Culture Collection). Cell cultures were carried out in accordance with 
recommendations. Silver nanoparticles with a nominal diameter of 20 nm were used as agents 
initiating biological response. Survival assessment was based on the neutral red accumulation 
in lysosomes of living cells. Measurements of intracellular superoxide anion generation in the 
mitochondria and cytoplasm, hydrogen peroxide and nitric oxide levels were performed using 
flow cytometry readings employing specific probes. Measurements of the production of 
mitochondrial hydrogen peroxide were conducted using the HyPer-mito reporter protein with 
flow cytometry techniques. 
Isolation of nucleic acids was carried out using the MagNA Pure LC 2.0 device (HepG2) 
and TRI reagent (LUHMES). Reverse transcription reactions were perforrmed using SuperScript 
III First-Strand Synthesis SuperMIX. Gene expression associated with oxidative stress on mRNA 
level was tested using commercially available set of primers (HOSL-1 – The human oxidative 
stress library). Gene expression of ABC family proteins on mRNA level was evaluated using 
 a commercially available set of primers (Roche). The concentration of nitrotyrosine was 
determined using commercially available ELISA kit (Merck Milipore), while the level of tyrosine 
nitration in the cell-free system was examined by measuring the fluorescence intensity of 
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nitotyrosine. The activity of antioxidant enzymes was determined by measuring the rate of 
changes in level of appropriate substrates with classical absorption spectroscopy methods. 
RESULTS 
The research presented in this dissertation is contained in three thematically related 
papers. In Glucose availability determines silver nanoparticles toxicity in HepG2 and Silver 
nanoparticles can attenuate nitrative stress, it was shown that the change in the concentration 
of available glucose in the culture medium resulted in the establishment of new redox balance. 
Stable redox status of the cells was attained 72 hours after the change in concentration of 
glucose as mitochondria activity modulating factor. The activity of enzymes related to 
antioxidant defense in cells grown in media supplemented with different glucose 
concentrations was evaluated. The adaptation process of cells to reduced concentration of 
glucose in the environment caused an increase in the importance of oxidative phosphorylation 
in cells metabolism. The observable increase in catalase, glutathione S-transferase, superoxide 
dismutase and glutathione reductase activities indicates the process of cells adaptation to new 
redox equilibrium. In addition, the expression profile of genes related to antioxidant defense 
was examined in cells grown at a lower glucose level. The adaptation process of the HepG2 cells 
was confirmed by the analysis of the transcriptome responsible mainly for the cell response to 
oxidative stress. The NOS2, GSTM5, ALB, MBL2, SCARA3 and CAT genes have been upregulated. 
At the same time, the decrease in the expression of genes related to glutathione metabolism 
(GSS, GSTZ1, GSTA4, GPX) suggests that the detoxification of reactive oxygen species produced 
as a result of lowering glucose concentration is carried out through rapid enzymatic reactions 
and not by small antioxidant molecules. In addition, gradual and chronic reduction of 
glutathione levels activates NFκB signal transmission pathway, which induces antioxidative 
response. 
 These observations allowed us to propose a mechanism that was decisive in the 
differences in survival of HepG2 cells cultured in varying glucose concentrations after treatment 
with silver nanoparticles.  
 The concentration of glucose in the culture medium is a factor modulating the toxicity 
of silver nanoparticles. Reducing the concentration of glucose intensified oxidative 
phosphorylation accompanied by increase in reactive oxygen species production, which in turn, 
resulted in elevating intracellular antioxidative defense mechanisms. The death of 10 % of cells 
in high glucose culture was caused by silver nanoparticles in concentration 1.4 times lower than 
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in case of culture sustained in low glucose for 24 hours and 7.6 times lower for culture sustained 
in low glucose for a month or more. 
 HepG2 cells were studied in context of production of hydrogen peroxide in the 
mitochondria and the production of reactive oxygen and nitrogen species in cytoplasm 
 It has been observed that silver nanoparticles caused oxidative stress in HepG2 cells, 
manifested by an increased concentration of H2O2 in the mitochondria by 18% in comparison 
to control cells. Culturing cells in a medium with reduced glucose concentration enabled the 
adaptation of cells to the conditions of increased oxidative stress due to increased activity of 
mitochondrial electron transport chain, so that no increase of H2O2 level was observed after 
treatment with silver nanoparticles. 
 Reduction of glucose concentration in the culture medium resulted in decrease in 
detected superoxide radicals at the cellular and mitochondrial level as well as decrease in 
intracellular peroxides. Silver nanoparticles caused an increase in the level of the mitochondrial 
superoxide anion and peroxides in cells grown in a medium with a higher concentration of 
glucose. The level of tested reactive oxygen species did not change after treatment with silver 
nanoparticles in cells cultured in a medium of lower glucose concentration. 
 To assess whether silver nanoparticles modulate tyrosine nitration in a cell-free system, 
in-vitro experiments were performed. Silver nanoparticles have been shown to lower the level 
of tyrosine nitration, most likely by accelerating the decomposition of peroxynitrite. 
 The hypothesis about the role of reactive nitrogen species and nitrogen stress product 
was verified by the assessment of nitrotyrosine concentration in HepG2 cells cultured in media 
with various concentration of glucose in the presence of silver nanoaprticles. 
 It was found that the endogenous level of nitrotyrosine in HepG2 cells was beyond the 
detection range of the used ELISA kit. Protein nitration caused by exogenous peroxynitrite 
increased was higher in cell cultured in low glucose medium. Nitrotyrosine was removed faster 
in cells cultured in a medium with a higher concentration of glucose, which is associated with 
higher proteasome activity. A similar effect was observed in cells grown in a medium with lower 
glucose concentration treated with silver nanoparticles, which, through activation of NRF2 
signaling pathway also cause an increase in proteasome activity. 
 In the above mentioned works we have shown that the toxicity of silver nanoparticles is 
strongly dependent on the cellular redox status, which is a consequence of the activity of the 
mitochondrial chain. This allowed the thesis that the cells whose metabolism strongly depends 
on glycolysis are more susceptible to damage caused by the action of silver nanoparticles, 
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neuronal cells being an example. The purpose of further experiments was to assess how the 
oxidative stress induced by silver nanoparticles can affect the mRNA profile of ABC proteins. 
The proteins from the ABC superfamily are very important for the proper functioning of 
neurons, conditioning the lipid balance in neuronal cells. The change in the level of these 
proteins is associated with the process of differentiation and the proper functioning of 
intracellular signal transmission. 
 In Exposure of human neurons to silver nanoparticles induces similar pattern of ABC 
transporters gene expression as differentiation: Study on proliferating and post-mitotic LUHMES 
cells biggest changes in the transcriptome of studied genes were observed for genes coding 
proteins from the ABCA family. A mechanism was proposed where the internalization of 
cholesterol-rich membrane fragments caused by endocytosis of silver nanoparticles increased 
the pool of cholesterol available for reactive oxygen species generated by silver nanoparticles. 
Oxysterols resulting from cholesterol oxidation can activate LXR, which determines the 
cholesterol homeostasis in the brain and increases the expression of the ABCA1 protein. 
 It has been found that intensely proliferating cells treated with silver nanoaprticles have 
similar pattern of expression profile changes as cells during differentiated into mature 
dopaminergic neurons. This may indicate that stress induced by nanoparticles in proliferating 
cells may cause disturbances of differentiation in fetal neuronal cells. 
CONCLUSIONS 
1. The availability of glucose modulates the toxicity of silver nanoparticles. This is related 
to the activation of antioxidant defense mechanisms through the increased activity of 
the mitochondrial chain and, consequently, increased production of reactive oxygen 
species. 
2. Cell types strongly dependent on glycolysis are more susceptible to the toxic effect of 
nanomaterials inducing oxidative stress. 
3. Silver nanoaprticles do not induce nitrogen stress, but affect post-translational protein 
modifications indirectly, by affecting the expression of proteins associated with 
protection against nitrative stress. 
4. Neuronal precursor cells are more susceptible to changes in gene expression for ABC 
proteins induced by silver nanoparticles than differentiated dopaminergic neurons. 
5. The process of neuronal differentiation results in a similar profile of changes in gene 
expression of ABC proteins as the biological activity of silver nanoparticles. 
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6. Silver nanoparticles activate LXR transcription factor which results in increased 
expression of the ABCA1 gene and possible disturbances in the cholesterol homeostasis. 
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Abstract 
Background: The increasing body of evidence suggest that nanomaterials toxicity is associated with generation of 
oxidative stress. In this paper we investigated the role of respiration in silver nanoparticles (AgNPs) generated oxida‑
tive stress and toxicity. Since cancer cells rely on glucose as the main source of energy supply, glucose availability 
might be an important determinant of NPs toxicity.
Methods: AgNPs of 20 nm nominal diameter were used as a model NPs. HepG2 cells were cultured in the media 
with high (25 mM) or low (5.5 mM) glucose content and treated with 20 nm AgNPs. AgNPs‑induced toxicity was 
tested by neutral red assay. Generation of H2O2 in mitochondria was evaluated by use of mitochondria specific 
protein indicator HyPer‑Mito. Expression of a 77 oxidative stress related genes was assessed by qPCR. The activity of 
antioxidant enzymes was estimated colorimetrically by dedicated methods in cell homogenates.
Results: AgNPs‑induced dose‑dependent generation of H2O2 and toxicity was observed. Toxicity of AgNPs towards 
cells maintained in the low glucose medium was significantly lower than the toxicity towards cells growing in the 
high glucose concentration. Scarceness of glucose supply resulted in upregulation of the endogenous antioxidant 
defence mechanisms that in turn alleviated AgNPs dependent ROS generation and toxicity.
Conclusion: Glucose availability can modify toxicity of AgNPs via elevation of antioxidant defence triggered by oxi‑
dative stress resulted from enhanced oxidative phosphorylation in mitochondria and associated generation of ROS. 
Presented results strengthen the idea of strong linkage between NPs toxicity and intracellular respiration and possibly 
other mitochondria dependent processes.
Keywords: Nanosilver, Oxidative stress, Antioxidant enzymes activity, Warburg effect
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Background
Nanoparticles (NPs) present in the environment, both of 
natural origin or anthropogenic, may have a significant 
impact on human health. Presence of the NPs in the body 
causes pathophysiological changes that might contribute 
to the development of cancer [1], cardiovascular diseases 
[2], respiratory tract inflammation [3], neurodegenerative 
diseases [4, 5], and many other pathologies [6].
Silver NPs (AgNPs) are among the one of the wid-
est use in everyday life products, despite their reported 
adverse effects against various cell lines and organisms. 
The accumulating body of evidence suggests that harmful 
action of AgNPs is associated with the induction of oxi-
dative stress [7, 8].
Oxidative stress is the most often described as an 
imbalance in cellular production and consumption of 
reactive oxygen species (ROS). Although ROS play an 
important role in many physiological processes, the 
redox imbalance is associated with many pathologies, 
such as Parkinson’s disease [9], Crohn’s disease, skin 
disease mediated by T cells, diabetes, cancer, Leigh syn-
drome and other mitochondrial diseases. Occurrence of 
the oxidative stress is often associated with disturbances 
in metabolic processes, such as deregulation of mito-
chondrial respiratory chain and/or glycolysis. Especially, 
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concentration of glucose has a significant effect on cel-
lular metabolism, as increased glucose level results in 
switching of cells metabolism from oxidative phosphoryl-
ation (OXPHOS) to glycolysis in various cell types [10], 
that in turn increases ROS production [11]. A proposed 
mechanism for this phenomenon involves an increase 
in intracellular calcium concentration resulting in mito-
chondrial fission through the function of dynamin-
like protein 1 [12], that leads to apoptosis [13]. It was 
reported that just 2-times higher glucose concentration 
(50 mM) than this used in standard high-glucose DMEM 
leads to apoptosis of HepG2 cells [14]. Results of in vitro 
studies on the link between increased glucose concentra-
tion and inhibition of cell proliferation in the model cell 
lines correlate with in vivo results. In patients with type 2 
diabetes a massive loss of beta-cells is observed, which is 
associated with oxidative stress induced by inhibition of 
glucose-6-phosphatase [15].
In physiological conditions majority of normal cells rely 
on OXPHOS, whereas cancer cells metabolism is based 
mostly on glycolysis (so-called Warburg effect) [16]. The 
Warburg effect may be an adaptation to the limited oxy-
gen supply, as an early development of cancer cells usu-
ally takes place in hypoxic environment of the growing 
tumor that has limited blood supply until its own vas-
culature is developed, or be due to the shutting down of 
mitochondria to prevent the apoptosis [17].
Since many reports describe induction of oxidative 
stress by NPs and there is a number of premises linking 
the toxicity of NPs to oxidative stress [18, 19], with par-
ticular emphasis on ROS generation in the mitochondria, 
it is of great interest to ascertain, whether the availability 
of glucose can modify NPs toxicity. Thus the aim of this 
study was to determine how the glucose availability and 
associated changes in redox balance will affect the toxic-
ity of NPs.
Results
Silver nanoparticles characteristic
Nanoparticle hydrodynamic diameter and zeta poten-
tial was measured by DLS. Hydrodynamic diameter 
of AgNPs of nominal size 20  nm was approximately 
8 times higher when measured in albumin contain-
ing buffer. The increase of NP’s hydrodynamic diam-
eter in protein containing medium is well recognized 
phenomenon usually ascribed to formation of pro-
tein corona [20]. High negative zeta potential value 
(−47.6 mV) confers high stability of the AgNPs disper-
sion and its resistance to aggregation. This was further 
confirmed by longitudinal analysis. Neither hydro-
dynamic diameter, zeta potential nor polydispersity 
index changed markedly over the 2 h that indicate no 
agglomeration (Table 1). Similar AgNPs behaviour and 
dispersion stability was previously observed in differ-
ent cell culture media [21].
Silver nanoparticles toxicity in high‑ and low‑glucose 
culture medium
Figure  1 shows the survival of HepG2 cells cultured in 
high- or low-glucose DMEM for 30 days or 24 h, followed 
by a 24 h-treatment with AgNPs. Comparison of the sur-
vival curves reveals a statistically significant protective 
effect of long term culture in low glucose medium against 
AgNPs induced toxicity. Transferring cells to low glucose 
medium for 24 h before the AgNPs treatment resulted in 
the similar, but yet smaller, not significant effect. 
The subsequent analysis of cell survival curves showed 
an decreasing difference in the effective concentrations 
of AgNPs necessary to induce toxicity at the particular 
level, between cells cultured on high- and low-glucose 
DMEM and cells cultured in low glucose medium for the 
long and short time (Table  2). The effective concentra-
tion of AgNPs, which resulted in 90 % survival of HepG2 
cells cultured for 1  month in low glucose medium, was 
5.5-times higher than this for cells incubated in low glu-
cose DMEM for 24 h and 7.6-times higher than this for 
cells maintained in regular, high glucose DMEM. On the 
contrary, the predicted effective concentration of AgNPs, 
which resulted in 10 % survival of long term low glucose 
cells was only 1.4-fold higher than those for short term 
low glucose or long term high glucose. In preliminary 
experiments, we checked if the different glucose content 
in the culture medium affects the growth rate of HepG2 
cells. No statistically important differences were found 
(Student’s “t” test, data not shown).
Oxidation of reporter protein with extracellular H2O2
In order to quantify the reactivity and sensitivity of the 
HyPer-mito protein in our system with respect to H2O2, 
we treated the HyPer-mito-transfected cells with exog-
enous H2O2 and measured the fluorescence of the HyPer-
mito protein. We found a hyperbolic dependence of the 
fluorescence on the concentration of H2O2, with a satura-
tion effect over 100 μM H2O2 (Fig. 2). Thus, the concen-
tration of 25 µM was chosen as a positive control for the 
further experiments, as the one enabling the upward and 
downward modification of fluorescence values.
Generation of H2O2 in mitochondria of HepG2 cells
Figure  3 presents generation of H2O2 in mitochondria 
of HepG2 cells cultured in different glucose concen-
trations and treated with AgNPs. H2O2 generation in 
mitochondria of cells cultured on regular, high glucose 
medium treated with AgNPs was higher than in control 
cells by 20  %, while the positive control (25  μM extra-
cellular H2O2) was greater by 40  % (Fig.  3a). Figure  3b 
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presents corresponding data for cells maintained on 
low glucose medium for 30  days. No statistically sig-
nificant difference in H2O2 generation by mitochondria 
was observed between control cells and AgNPs-treated 
ones. While, the positive control showed only 16  % 
increase in HyPer-mito protein derived fluorescence, 
as compared with control cells. In control cells, without 
AgNPs, sustained on media with lower glucose concen-
tration higher fluorescence intensity can be observed 
than in those sustained on media with high glucose 
content.
Expression of oxidative stress related genes
To further examine the mechanism underlying differ-
ent susceptibility of HepG2 cultured on low- and high-
glucose medium to AgNPs, the expression of genes 
related to the cellular response to oxidative stress was 
evaluated (Table 3). A marked increase of expression of 
several genes coding proteins directly involved in oxi-
dative defence was observed. Among those, the most 
notable change was observed for ALB (8.6-fold upreg-
ulation), CAT (3.5-fold upregulation), GLRX (2.3-fold 
upregulation), GPX3 (2.2-fold upregulation), GSTM3 
(2.2-fold upregulation), GSTM5 (72-fold upregulation), 
GSTT1 (2.6-fold upregulation), MBL2 (4.5-fold upreg-
ulation), NCF1 (2.9-fold upregulation), and SCARA3 
Fig. 1 Toxicity of AgNPs (2.5–50 µg/cm3) for HepG2 cells cultured in the high‑ or low‑glucose medium. Curves were compared with extra sum of 
square F test, p = 0.0007, N = 12 (5.5 mM glucose for 30 days, 25 mM glucose) and 9 [5.5 mM glucose (48 h)]. Graphed points represent means with 
SD
Table 1 Hydrodynamic diameter, zeta potential and   
aggregation over  2  h of  silver nanoparticles used in  this 
work of nominal size 20 nm
Results are presented as a mean ± SD. Means were compared by Student’s t test 
(n = 3)
a Denotes statistically important difference from the control (time 0 h)
Time (h) Hydrodynamic 
diameter (nm)
Polydispersity 
index
Zeta potential 
(mV)
0 160.3 ± 2.1 0.31 ± 0.04 −47.6 ± 0.5
0.5 156.1 ± 5.3 0.31 ± 0.03
1 160.5 ± 3.4 0.30 ± 0.01
2 151.8 ± 4.2a 0.30 ± 0.03
Table 2 The AgNP concentrations necessary to induce cell death at the given survival level
Values of each IC were compared by ANOVA accompanied by Tukey’s post test
Values represent means ± half of respective confidence intrerval, α = 0.05, n = 3
a Denotes statistically important difference between low glucose (30 days) and other cultures
b Means that viability of each culture differs from other two
Dead cells % AgNP concentrations necessary to induce cell death at the given survival level (µg/cm3)
High glucose culture Low glucose culture (24 h) Low glucose culture (30 days)
10b 1.81 ± 0.41 2.52 ± 0.57 13.84 ± 2.05
25b 4.60 ± 0.58 5.82 ± 0.73 22.91 ± 1.93
50b 11.70 ± 0.93 13.45 ± 1.15 37.94 ± 7.63
75a 29.75 ± 4.46 31.06 ± 4.99 62.83 ± 22.235
90a 75,61 ± 19.35 71.77 ± 19.33 104 ± 21.63
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(3.5-fold upregulation). Interestingly, several gene were 
downregulated. The most significantly down-regulated 
genes include: CSDE1, GSS, OXSR1, AOX1, SRXN1, 
KRT1, GSTZ1, GSTA4, GPX7, SOD1, NCF2, TXNRD2, 
EPX, PRNP, CYGB, MPV17, PRDX3, NME5, PREX1. 
Noteworthy, several of down regulated genes encode 
proteins involved in the glutathione synthesis and 
metabolism.
The expression of 33 genes (among 72 studied) was 
not affected the by long term culture on the low glu-
cose medium. These genes include ALOX12, ANGPTL7, 
APOE, ATOX1, BNIP3, DHCR24, DUSP1, EPHX2, 
FOXM1, GLRX2, GPR156, GPX1, GPX2, GPX4, GSR, 
GSTP1, LPO, MGST3, MSRA, MT2A, OXR1, PDLIM1, 
PRDX2, PEDX4, PRDX5, PRDX6, PTGS1, RNF7, SEPP1, 
SIRT2, SOD3, STK25, TXNRD1(Additional file 1) .
Activity of key antioxidant defence enzymes
In addition to the transcriptome analysis, enzymatic 
activity of the proteins playing a crucial role in the cellu-
lar antioxidant defence was evaluated (Table 4). Catalase 
activity was elevated 1.19 times, whereas Zn-Cu superox-
ide dismutase activity was elevated 1.37 times. Glutatione 
S-transferase and glutatione reductase activities were 
elevated 1.69 and 1.4 times, respectively.
Discussion
HepG2 cells are a well established model for study of the 
effects of glucose on cellular metabolism and response 
to different stimuli, as these cells can be easily grown in 
both, low- and high-glucose media [22]. Being a cell line 
derived from the liver, one of the target organs for nano-
particle mediated toxicity, HepG2 cells are also a well rec-
ognized model for nanotoxicity testing, including AgNPs 
toxicity. Toxicity of AgNPs has been demonstrated across 
different systems ranging from the model cell lines 
in vitro to small animals. In the present study, cell viabil-
ity was evaluated by the Neutral red assay. This assay is 
less prone to artefacts than the commonly used MTT 
assay, as the reduction of tetrazolium dyes is strongly 
dependent on the metabolic state of the cell, in particular 
on the activity of NAD(P)H-dependent oxidoreductases 
[15]. Neutral red viability test is based on dye accumu-
lation in lysosomes of viable cells and seems to be less 
dependent on fluctuations in the redox state of the cells. 
However, despite the test used, published results repeat-
edly confirm toxicity of AgNPs [8]. Also the current study 
confirmed the toxicity of AgNPs to HepG2 cells in vitro.
Analyzing the survival curves for HepG2 cells culti-
vated in media with different glucose concentration and 
treated with AgNPs we observed an increase in resistance 
Fig. 2 Influence of extracellular H2O2 on fluorescence intensity of 
reporter protein HyPer‑Mito in HepG2 cells cultured on high glucose 
medium. Marked points represent mean ± SD, N = 3
a b
Fig. 3 Generation of H2O2 in mitochondria measured with HyPer‑mito in HepG2 cells growing on high glucose (a) and low glucose medium (b) 
in the presence of 25 μg/cm3 AgNPs. Extracellular H2O2 (25 μM) was used as a positive control. Results were normalized versus control (untreated 
cells) and statistical importance of differences was calculated with ANOVA accompanied by Tukey`s post hoc test. # indicates statistically important 
difference from the respective control, p < 0.05, N = 3. * denotes statistically important difference between AgNPs treated cell and the respective 
positive control, p < 0.05, N = 3. Values represent means with SD
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to the NPs in cells cultured on low glucose for 30 days, 
as compared to cells cultured on high glucose medium 
or on low glucose medium for 24  h (Fig.  1). This effect 
is especially visible at the high survival levels, e.g. the 
AgNPs concentrations necessary to reduce the survival of 
HepG2 cells growing on low glucose medium for 30 days 
to 90 and 75 % were approximately 7.6 and 5 times higher 
than those necessary to reduce the survival of the cells 
growing on high glucose medium to the same survival 
level, respectively (Table  2). Interestingly, the difference 
decreases along with the decrease of the survival level, as 
the estimated AgNPs concentrations necessary to reduce 
the survival of HepG2 cells growing on low glucose 
medium for 30 days to 25 and 10 % were only 2.1 and 1.4 
times higher than those necessary to reduce the survival 
of cells growing on high glucose medium to the same 
survival level, respectively (Table 2). There was no differ-
ence between cells growing on low glucose medium for 
24 h and those growing on high glucose medium. These 
results clearly point to the existence the adaptive mech-
anisms in low-glucose-growing cells that diminish the 
toxic effect of AgNPs, but also indicate a limited capac-
ity of the adaptive mechanisms, as the difference between 
the low- and high-glucose growing cells decreased with 
the decrease of the survival level.
Although the mechanisms of the AgNPs toxicity is still 
under debate, it is most likely associated with the induc-
tion of oxidative stress. Induction of the oxidative stress 
by AgNPs has been proven in different systems in  vitro 
and in vivo [7, 8, 22]. It is usually associated with exces-
sive generation of free radicals due to the dysfunction of 
mitochondria [23] and/or activation of ROS generating 
enzymes, e.g. NADPH reductase [24]. Whereas fluores-
cent probes commonly used to assess ROS generation are 
either non-specific or difficult to target to the particular 
cell compartment, in this work we directly and specifi-
cally confirmed generation of H2O2 in mitochondria of 
AgNPs treated HepG2 cells, by the use of mitochondria 
targeted, H2O2 specific HyPer-mito reporter protein. 
AgNPs treatment of HepG2 cells growing on the stand-
ard high glucose medium resulted in the increase of 
H2O2 generation in the mitochondria by 40  %, as com-
pared with control, untreated cells (Fig. 3a). This is con-
sistent with the previous report on AgNP dependent 
ROS generation in HepG2 cells [21], and the report of 
generation of H2O2 in bronchial epithelial cells (BEAS-
2B) [25]. In contrast, AgNPs treatment did not increase 
generation of H2O2 in HepG2 cells grown on low-glucose 
medium, in concordance with the survival data described 
above. A plausible, coming to the mind explanation of 
this phenomenon is an intensification of the antioxidant 
defence systems that diminish AgNPs-induced ROS 
toxicity. In parallel with this interpretation, treatment 
with exogenous H2O2 resulted in an only 16  % increase 
in H2O2 detected inside mitochondria of cells grown on 
low glucose, whereas the same treatment resulted in 40 % 
Table 3 Expression of genes involved in redox regulation in cells
Results are presented as fold change of expression in HepG2 cells cultured on low glucose relative to expression in HepG2 cells cultured on high glucose along with 
95 % confidence intervals. Only statistically important results were combined in this table (p < 0.05)
Up‑regulation Down‑regulation
Gene Expression 95 % CI Gene Expression 95 % CI Gene Expression 95 % CI Gene Expression 95 % CI
GSTM5 72,004 67.62–76.43 GPX3 2.199 1.88–2.48 CSDE1 0.801 0.69–0.92 NCF2 0.626 0.57–0.69
ALB 8.574 8.17–9.24 DUOX1 1.853 1.29–2.68 GSS 0.79 0.619–0.990 TXNRD2 0.564 0.48–0.67
MBL2 4.511 3.92–5.50 EPHX2 1.832 1.66–2.13 OXSR1 0.765 0.63–0.97 EPX 0.354 0.16–0.65
SCARA3 3.547 1.32–5.23 NUDT1 1.803 1.26–2.57 AOX1 0.758 0.64–0.85 PRNP 0.334 0.27–0.42
CAT 3.531 2.47–5.30 PRDX‑1 1.713 1.32–2.22 SRXN1 0.734 0.56–0.89 CYGB 0.325 0.29–0.36
NCF1 2.908 1.52–5.91 PNKP 1.295 1.14–1.49 KRT1 0.704 0.53–0.98 MPV17 0.289 0.20–0.42
GSTT1 2.688 2.32–3.25 NUDT2 1.275 1.12–1.51 GSTZ1 0.702 0.53–0.92 PRDX3 0.227 0.09–0.56
GSTM3 2.389 1.94–3.03 TTN 1.254 1.12–1.43 GSTA4 0.686 0.60–0.82 NME5 0.138 0.09–0.19
SGk2 2.335 2.09–2.55 CYBA 1.24 1.17–1.32 GPX7 0.657 0.58–0.77 PREX1 0.108 0.07–0.20
GLRX 2.303 1.22–6.16 GSTM2 1.143 1.03–1.32 SOD1 0.657 0.45–0.92
Table 4 Enzymatic activity of  the key players of  cellular 
antioxidative defence
Enzyme activities were compared with t test (n = 4, α = 0.05)
a Denotes statistical important difference between HepG2 cells cultured on 
high glucose medium and low glucose medium for 30 days. Values represent 
means with standard deviation
Enzyme Activity (u/mg protein)
25 mM glucose 5.5 mM glucose
Catalase 75.19 ± 6.62 89.81 ± 7a
Glutathione S–transferase 0.97 ± 0.16 1.64 ± 0.26a
Superoxide dismutase 582 ± 75.2 803 ± 87.5a
Glutathione reductase 9.21 ± 1.59 12.94 ± 1.19a
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increase of H2O2 detectable in mitochondria of the high 
glucose growing cells.
Indeed, analysis of the enzymatic activity of the key 
enzymes of the cellular antioxidant defence system 
revealed statistically significant increase of the activi-
ties of all tested enzymes, including catalase, glutathione 
S-transferase, glutathione reductase and superoxide dis-
mutase (Table 4). While the acute oxidative stress usually 
results in a cell membrane injury and damage to macro-
molecules and organelles leading to cell death, the activa-
tion of antioxidant adaptive response at a moderate level 
of oxidative stress is well recognized phenomenon. This 
diverse cellular response is connected with activation 
of different cellular signalling pathways, such as MAP 
kinases cascade and/or pathways associated with redox-
sensitive transcription factors, such as HIF-1, NF-κB and 
Nrf-2 [26–28] The activation of NF-κB transcription fac-
tor and an increased expression of its target genes was 
also reported in HepG2 cells treated with AgNPs [29]. In 
addition, adaptation of HepG2 cells to AgNPs induced 
oxidative stress has been already proposed as a mecha-
nism explaining the differences in response to nanosilver 
between HepG2 and A549 cell lines [30]. In that work a 
different AgNPs susceptibility of HepG2 and A549 cells 
was linked to upregulation of pro-proliferative and anti-
apoptotic signalling pathways.
In our experimental setup, an observed increase of 
antioxidant enzymes activities resulted as an adaptation 
to low glucose condition and accompanied increase of 
oxidative stress. The impact of glucose on cell metabo-
lism has been widely studied and there are numerous 
data on the effects of glucose availability on oxidative 
stress induction. High glucose concentration leads to 
increased protein glycation, but provides more sustain-
able environment for cell growth. However, increased 
mitochondrial protein glycation and accumulation of 
advanced glycation end-products may lead to mitochon-
drial dysfunction and oxidative stress, as has been shown 
on C. elegans [31] and human cells [32].
On the other hand, ROS generation has been also asso-
ciated with low glucose availability [33], which is con-
sistent with reports of switching cell metabolism from 
glycolysis to OXPHOS [10, 34]. In physiological condi-
tions the prevalent way for energy supply in cancer cells 
is glycolysis, thus glucose scarcity forces the metabolic 
switch back to OXPHOS (so-called the Warburg effect) 
[35]. The phenomenon of metabolic switch between gly-
colysis and respiratory chain in response to glucose avail-
ability was observed in a variety of experimental setups, 
ranging from yeast to mammalian cell lines [36, 37]. The 
Warburg effect was firstly explained by irreversible dam-
age to the elements of oxygen-dependent pathway of 
OXPHOS in cancer cells. However, this explanation was 
questioned by the recent investigations showing an intact 
functionality of mitochondrial OXPHOS in many cancer 
cells [38–40] and the studies describing similar effect in 
non-cancer, proliferating cells, which were not supposed 
to have the OXPHOS pathway irreversibly damaged [41]. 
Moreover, many authors consider the Warburg effect as a 
result of suppression of mitochondrial OXPHOS due to 
enhanced glycolysis rather than defects in its function-
ality. If glycolysis is inhibited in cancer cells, the func-
tion of mitochondrial OXPHOS can be restored [38, 
42, 43]. Indeed, also in our experimental setup, deple-
tion of glucose supply resulted in metabolic switch and 
enhanced production of H2O2 in mitochondria due to the 
OXPHOS. As oxidative stress prolonged, cells adopted to 
the new situation by elevating the activity of key antioxi-
dant defence enzymes (Table 4).
This was further confirmed by the transcriptome analy-
sis. The level of catalase gene mRNA (CAT) was elevated 
3.5-times in cells cultured in the low glucose medium, 
as compared to cells cultured in high glucose medium. 
Catalase is a key peroxisome antioxidant enzyme detoxi-
fying H2O2 and plays a protective role against H2O2-
induced oxidation in nearly all aerobic organisms. A 
similar increase of the CAT expression was observed in 
response to oxidative stress [44] and low glucose condi-
tion [45]. Glucose scarcity resulted also in upregulation 
of the Scavenger Receptor Class A, Member 3 (SCARA3) 
mRNA level (3.5 times). Being a macrophage scavenger 
receptor-like protein, the Scara3 protein has been shown 
to deplete ROS and other harmful products of oxidation, 
thus playing an important role in protecting cells from 
oxidative stress. Brown et al. [46] reported an increase of 
SCARA3 expression in cells treated with H2O2.
Of note is the 50-times increase of mRNA level of 
GSTM5 gene that belongs to the mu class of glutathione 
S-transferases (Table  3), although accompanied only by 
1.7 times higher activity of the enzyme (Table  4). The 
Gstm5 protein functions in detoxification of electrophilic 
compounds, including carcinogens, therapeutic drugs, 
environmental toxins and products of oxidative stress, 
by conjugation with reduced glutathione. Overexpres-
sion of GSTM5 has been already reported due to the gen-
eration of ROS in low-glucose medium [47]. A similar 
phenomenon was found in AgNPs treated Arabidopsis 
thaliana roots [48] that suggest a common mechanisms 
of response to the increased mitochondrial generation 
of ROS. A marked up-regulation of expression was also 
observed for albumin gene (ALB). Albumin is a liver-
derived, the most abundant plasma protein well rec-
ognized for its antioxidant properties [49, 50], Human 
serum albumin was shown to prevent neuronal death in 
murine cortical cell cultures exposed to oxidative stress 
generated by H2O2 [51].
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In addition to antioxidant proteins and enzymes, 
another markedly up-regulated gene was a Mannose-
Binding Lectin (Protein C) 2, Soluble (MBL2), which 
plays an important role in innate immune defence sys-
tem. Another important function of MBL2 protein is 
binding to the apoptotic and necrotic cells that facilitate 
their uptake by macrophages. MBL2 is produced in the 
liver in a response to infection, typically associated with 
generation of oxidative stress [52].
Noteworthy, although Zn-Cu superoxide dismutase 
activity was still elevated, transcritpome analysis revealed 
that its mRNA transcription was already shut down 
(Tables  3, 4). This discrepancy can be easily explained 
by increased activity of mitochondrial respiratory chain 
induced by low glucose condition and mutually associ-
ated increase of its unwanted by-product, superoxide 
anion radical. Moreover, the Neutrophil Cytosol Factor 
1 (NCF1) mRNA level was increased 2.9 times. NCF1 
protein is a subunit of NADPH oxidase, the enzyme also 
producing superoxide anion radical. Superoxide anion 
radical is subsequently converted into H2O2 by superox-
ide dismutase. As superoxide anion radical is less reac-
tive than H2O2-derived hydroxyl radical and due to the 
negative charge does not easily cross the cell membranes, 
it is probably less dangerous and more favourable as an 
excess, resident ROS than H2O2. In agreement, catalase 
activity and transcription was elevated (Tables 3, 4).
Surprisingly, low glucose concentration in culture 
medium resulted in down-regulation of several genes 
involved in synthesis and metabolism of glutathione 
(GSS, GSTZ1, GSTA4, GPX), This suggest that general 
detoxification of ROS generated in low glucose condition 
is carried out with fast enzymatic reactions rather than 
small molecule antioxidants, such as glutathione. Down-
regulation of glutathione synthesis is in line with up-
regulation of glutathione S-transferase, that deplete the 
reduced glutathione by conjugating with nucleophiles, 
the conjugates are further removed by ABC-type trans-
porters [53]. Since glutathione may act as an anti- and 
pro-oxidant [54], it seems favourable to diminish glu-
tathione redox-cycling mechanism in chronic oxidative 
stress condition. Moreover, in chronic oxidative stress 
GSH depletion may promote pro-survival pathways. 
Whereas, a rapid GSH depletion induces pro-apoptotic 
pathway [55], its slow and prolonged depletion triggers 
NFkB signalling pathway and associated anti-oxidative 
and pro-survival response [56]. Activation of NFkB sig-
nalling pathway is repeatedly reported in oxidative stress 
condition of different origin, including AgNPs treatment 
[29]. However, it must be remembered that different sig-
nalling pathways often stimulated by the same condition 
(e.g. oxidative stress) may interact each other, as recently 
reviewed for NFkB and NRF/KEAP signalling pathways 
[57] and many others [58] or even counteract, e.g. miti-
gation of oxidative stress induced NFkB pathway activity 
by HIF-1 [59]. Thus, a net effect of signalling pathways 
stimulation is a result of pathways crosstalk and local, 
intracellular context.
Conclusions
We have shown that glucose availability can modify 
toxicity of AgNPs via elevation of antioxidant defence 
triggered by oxidative stress resulted from enhanced 
OXPHOS in mitochonddria and associated generation 
of ROS. Since the mechanism does not depend on the 
toxic factor but the activity of mitochondria, it seems to 
be universal, regarding not only AgNPs, but all oxidative 
stress generating agents, e.g. another nanomaterials, pes-
ticides and many others. Moreover, our results suggest 
that cells relying strongly on glycolysis (such as cancer 
cells) might be more prone to toxic action of nanoma-
terials that normal cells, whose metabolism is based on 
the OXPHOS. Further, higher survival of cells cultured in 
environment forcing the activation of mitochondrial res-
piratory chain, as compared with glycolysis based ones, 
gives a good prognosis for use of nanomaterials in medi-
cal and pharmaceutical application.
On the other hand, few crucial cell types in the human 
body strongly rely on glycolysis, including brain, muscle 
and liver cells [60] that makes them more susceptible to 
the toxic action of nanomaterials than OXPHOS based 
cells, unless have other mechanisms elevating antioxidant 
response.
Finally, our results suggest that local microenviron-
ment, such as local availability of glucose, might be 
a factor promoting an adaptive abilities of cells, and 
modifying their response to xenobiotics, including 
nanomaterials.
Methods
Cell culture and treatment
HepG2 cell line was purchased from the American Type 
Culture Collection (ATCC). The cells were cultured in 
75  cm3 Nunclon flasks in glucose supplemented Dul-
becco’s Modified Eagle Medium (DMEM). Medium 
described in this paper as a high-glucose medium 
contained glucose at the concentration of 4.5  g/dm3 
(25  mM), whereas low glucose medium contained 1  g/
dm3 glucose (5.5 mM). Both variants of the medium were 
supplemented with 10  % FCS (Gibco). Glucose concen-
trations roughly reflect average blood sugar level and 
heavy hyperglycaemic level [61]. Cells were maintained 
in a 5 % CO2 atmosphere at 37 °C at 95 % relative humid-
ity. Cells described further as being cultured for long 
period of time on low glucose were passaged for 30 days 
before experiments in medium with 5.5  mM glucose. 
Page 8 of 10Zuberek et al. J Nanobiotechnol  (2015) 13:72 
Cells referred to as sustained for short period of time on 
low glucose were incubated in medium with 5.5 mM glu-
cose for 48 h, including AgNPs treatment.
Silver nanoparticle preparation
The stock suspension (2  mg/cm3) of the AgNPs of a 
20  nm nominal diameter (PlasmaChem, Germany) was 
prepared as previously described [13]. In brief, AgNPs 
were triturated in agate mortar, then 2  mg of NPs was 
suspended in 800 µL of water. Suspension was sonicated 
(4.2 kJ/cm3) with OmniRuptor 4000 and then 100 µL of 
15 % albumin which was followed by addition of 100 µL 
of tenfold concentrated PBS (1.37 M NaCl, 27 mM KCl, 
80  mM Na2HPO4, 20  mM KH2PO4). Intermediate dilu-
tions were made in DMEM with the corresponding high 
or low glucose content.
Nanoparticles’ hydrodynamic diameter and zeta poten-
tial was measured by dynamic light scattering (DLS, Mal-
vern, UK). Both the hydrodynamic diameter and zeta 
potential of the samples were measured at 25  °C with a 
scattering angle of 173°. The particle concentration for 
hydrodynamic diameter measurements in each sample 
was 2  mg/cm3 in the preparation buffer. Measurements 
were done in triplicate with over 14 sub-runs. The pH 
value of the suspensions was 7.1.
A detailed characterization of this batch of AgNPs, 
including different preparation protocols, dispersion, 
aggregation and stability in different culture media, as 
well as silver ion release, was previously described in [21, 
62]
Measurement of H2O2 generation in mitochondria
HepG2 cells were suspended at a density of 1 × 106 cells/
cm3 and centrifuged for 10  min at 200×g in 1.5  cm3 
Eppendorf tube. The supernatant was removed, the cells 
were resuspended in 0.8  cm3 of hypoosmolar buffer 
(Eppendorf cat no 940002001), and 10 μg of HyPer-mito 
plasmid (EVROGEN, Russia, cat.# FP942) was added. 
Cells were transferred to a cuvette and electroporated 
with three 10 μs pulses with a voltage of 500 V (Multipo-
rator®, Eppendorf ).
After electroporation cells were plated on 6-well plate 
(Nunclon) in 3  cm3 of DMEM medium with an appro-
priate glucose concentration (5.5 or 25 mM). After 24 h 
of culture cells were trypsinized with 0.25 cm3 of 0.25 % 
trypsin, suspended in 0.75  cm3 of appropriate DMEM 
medium and transferred to cytometry tubes. Fluores-
cence intensity of transfected cells was measured using 
a LSRII flow cytometer in the FITC channel. Transfec-
tion efficiency was found to be at the level of 60–70  %. 
For further analysis only cells that exhibited fluorescence 
above the maximum autofluorescence of mock trans-
fected cells were used.
To check the approximate range of H2O2 detection by 
the product of the reporter vector, HyPer-mito plasmid 
transfected HepG2 cells were cultured in 25 mM glucose 
and titrated with extracellular H2O2. Five minutes after 
H2O2 addition cells’ fluorescence was read in a LSRII 
cytometer.
Neutral red viability test
Cells were plated on 96-well plates (Nunclon) at a den-
sity of 15 000 cells per well in a final volume of 0.1 cm3. 
After 24 h, an appropriate aliquot of AgNPs was added to 
achieve concentrations in range from 2.5 to 50 µg/cm3 in 
a final volume of 0.2 cm3 After next 24 h incubation, the 
medium was removed and cells were washed twice with 
0.15  cm3 per well of PBS solution. The cells were then 
flooded with 0.1 cm3 of neutral red solution (50 µg/cm3 
neutral red in the culture medium). After a 4-h incuba-
tion at 37  °C in an atmosphere of 5  % CO2 neutral red 
solution was discarded, the cells washed twice with 
0.15 cm3 PBS and 0.15 cm3 of fixative (50 % of 96 % etha-
nol, 49 % H2O, 1 % acetic acid) was added to each well. 
The plate was shaken for 15 min and the absorbance was 
measured at a wavelength of 540 nm using an EnVision® 
Multilabel Reader (Perkin-Elmer).
Gene expression analysis
Total RNA was isolated from 106 HepG2 cells employing 
MagNA Pure LC 2.0 Instrument (Roche) according to the 
manufacturer’s protocol. Genomic DNA was removed by 
DNase I digestion (RNase free DNAse, Life Technolo-
gies) and 1 µg of the total RNA was reverse-transcribed 
using the SuperScript™ III First-Strand Synthesis Super-
Mix (Life Technologies). qPCR analysis was performed 
with C1000 Thermal Cycler–CFX96 Real-Time System 
(BioRad).
The human oxidative stress library (HOSL-1) primers 
(RealTimePrimers.com) were used to assess the expres-
sion of oxidative stress related genes using iQ SYBR 
Green Supermix (BioRad). After 3 min of an initial acti-
vation and denaturation step at 95 °C, 40 cycles of dena-
turation at 95  °C for 10  s, annealing/extension at 60  °C 
for 45 s followed by melt curve analysis (55–95 °C, 0.5 °C 
increment, 5 s/step) were performed. cDNA was omitted 
in non-template control. The mRNA level was calculated 
using the ΔΔct method (Rest, Qiagen), and normalized to 
the housekeeping gene (ACTB), as a control.
Assessment of antioxidant enzymes activity in cells 
homogenate
For biochemical analysis cells were plated in 75 cm3 Nunc 
flasks, 3 × 106 cells per flask and cultured in DMEM with 
low or high glucose concentration at 5  % CO2 atmos-
phere, 37  °C and 95  % relative humidity. For enzymatic 
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activity estimation, the cells were harvested by trypsini-
zation when cultures reached 80  % confluence (roughly 
after 48 h culture), lysed with 0.1 % Triton/1 mM EDTA 
solution and frozen overnight at −20  °C. All measure-
ments were conducted in 96-well NUNC plates in an 
EON spectrophotometer (BioTek).
Catalase activity of samples was determined by assess-
ing their ability to decompose H2O2 as previously 
described [63]. Gluthatione S-transferase activity was 
determined with colorimetric method as described by 
Rise-Evans et  al. [64]. SOD activity was assessed by the 
NBT reduction method [65]. Glutathione reductase 
was assayed on the basis of NADPH oxidation [66]. The 
results were referenced to protein concentration in the 
samples and enzymatic activity was calculated by com-
parison in comprehension with enzyme standards. All 
methods were adapted to 96-well microplates by scaling 
down the volume of reagents.
Statistical evaluation
All statistical evaluations were made using a GraphPad 
Prism 5, Microsoft Excel and REST software. Curves 
graphed in Fig.  1 were compared utilizing extra sum of 
square F test. Difference between various inhibitory con-
centrations summarized in Table  2 were calculated by 
ANOVA with Tukey`s post hoc test. Statistical signifi-
cance of differences in generation of hydrogen peroxide 
induced by different treatments, summarized in Fig.  3 
was calculated with ANOVA followed by Tukey`s post 
hoc test. The expression ratio results (Table  3) of the 
investigated transcripts were tested for significance by 
a  Pair Wise Fixed Reallocation Randomisation Test and 
error is expressed as a standard error (SE) estimated via 
Taylor algorithm (REST software) [67]. Enzymes activi-
ties summarised in Table 4 were compared with t test.
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A B S T R A C T
We have reported previously that glucose availability can modify toxicity of silver nanoparticles (AgNPs) via
elevation of antioxidant defence triggered by increased mitochondrial generation of reactive oxygen species. In
this study, we examined the eﬀect of glucose availability on the production of reactive nitrogen species in HepG2
cells and modiﬁcation of nitrative stress by AgNPs. We found that lowering the glucose concentration increased
expression of genes coding for inducible nitric oxide syntheas, NOS2 and NOS2A resulting in enhanced
production of nitric oxide. Surprisingly, AgNPs decreased the level of nitric oxide accelerated denitration of
proteins nitrated by exogenous peroxynitrite in cells grown in the presence of lowered glucose concentration,
apparently due to further induction of protective proteins.
1. Introduction
In recent years interest in silver nanoparticles and their applica-
tions has increased mainly because of the important antimicrobial
activities of these nanomaterials, allowing their use in several industrial
sectors. These broad applications, however, increase human exposure
and thus the potential risk related to their short- and long-term
toxicity. There is increasing concern with respect to the biological
impacts of the use of silver nanoparticles on a large scale, and the
possible risks to the health and environment [1]. A large number of in
vitro studies indicate that AgNPs are toxic to the mammalian cells
derived from skin, liver, lung, brain, vascular system and reproductive
organs. Interestingly, some studies have shown that these particles
have the potential to induce genes associated with cell cycle progres-
sion, DNA damage and apoptosis in human cells even at non-cytotoxic
doses [2].
An important mode of action of AgNPs is the induction of oxidative
stress. Oxidative stress is deﬁned as a disturbance in the balance
between the production of reactive oxygen species (free radicals) and
antioxidant defenses or, more recently, as disruption of redox signaling
and control [3]. Numerous data exist in the literature that both ROS
and reactive nitrogen species (RNS) are produced in a well-regulated
manner to help maintain homeostasis at the cellular level in the normal
healthy tissues, play an important role as second messengers, and
regulate cellular function by modulating signaling pathways [4].
However, excessive production of ROS and RNS results in damage to
all components of the cell, including proteins, lipids, and DNA.
Stress induced by reactive nitrogen species (RNS) is referred to as
nitrative (nitrosative) stress. Nitric oxide (NO), endogenous precursor
of RNS, is produced mainly by nitric oxide synthases (NOS) in various
cell types such as endothelial cells [5], liver cells [6] and macrophages
[7]. It participates in cellular signaling [8] and controls the activities of
several enzymes, ﬁrst of all guanyl cyclase [9]. At the cellular level, NO
aﬀects cell apoptosis and participates in immune defense [10] while at
the organismal level its main function is the control of blood pressure
[11].
While NO shows a limited reactivity, a product of its reaction with
the superoxide radical anion, peroxynitrite ONOO-, is a reactive
oxidant and nitrating agent. The reaction of peroxynitrite formation
is characterized by a very high rate constant, of about 1.6*1010 [12] so
it proceeds in vivo even though the concentrations of both substrates
are low and is enhanced when production of the precursors is increased
or when the activity of superoxide dismutase is compromised (which
occurs in many pathologies). Peroxynitrite is unstable under physiolo-
gical conditions, one way of its decomposition leading to the formation
of the hydroxyl radical and nitrogen dioxide [13]. It is therefore a
strong oxidant and nitrating agent modifying proteins, lipids and
nucleic acids and depleting cellular antioxidants. Proteins are subject
to various modiﬁcations by peroxynitrite, the most typical modiﬁcation
being nitration of tyrosine residues [14,15].
Oxidative stress induced by engineered NP is due to acellular
factors such as particle surface, size, composition, and presence of
metals, while cellular responses include mitochondrial respiration, NP-
cell interaction, and immune cell activation are responsible for ROS-
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mediated damage. NP-induced oxidative stress responses are torch
bearers for further pathophysiological eﬀects including genotoxicity,
inﬂammation, and ﬁbrosis as demonstrated by activation of associated
cell signaling pathways [16]. Various factor, among them glucose
availability, modulate AgNPs-induced oxidative stress [17] or the
presence of other xenobiotics. The main cellular source of superoxide
is the respiratory chain in the mitochondria [18]. If oxidative stress
caused by increased activity of the respiratory chain is of moderate
intensity, the cell can adapt to its occurrence [17], which results in an
increased resistance to oxidative stress induced by other agents, e. g.
AgNPs. Adaptation is mainly due to activation of the Nrf2 pathway
[19], NF-κB [20] or the MAPK pathway [21]. Metabolic pathways
regulated by oxidative stress control the level of many proteins
responsible for the cellular redox balance.
In this paper, we have studied how AgNPs can modulate nitrative
stress induced by increased production of reactive oxygen species in
mitochondria and increased activity of iNOS in HepG2 cells.
2. Materials and methods
2.1. Cell culture
HepG2 cell line was derived from hepatocellular carcinoma of a
Caucasian male adolescent. HepG2 cells can be cultured in media
containing diﬀerent concentrations of glucose [22] and are a well
recognized model for nanotoxicity testing. HepG2 cell line originated
from the American Type Culture Collection (ATCC). The cells were
cultured in Dublecco's Modiﬁed Eagle Medium (DMEM) supplemented
with FBS (Gibco). Cells were maintained in a 5% CO2 atmosphere at
37 °C, at 95% relative humidity. During passages cells were detached
from culture surface with trypsin solution (0.25 trypsin, 1 mM EDTA in
PBS, 10 min incubation in culture conditions).
2.2. Neutral red viability assay
Cells were plated on 96-well plates (Nunclon) at a density of 15,000
cells per well in a ﬁnal volume of 0.1 cm3. After 24 h, an appropriate
aliquot of AgNPs was added to achieve concentrations in range from
2.5 to 50 µg/cm3 in a ﬁnal volume of 0.2 cm3. The procedure of
preparation of nanoparticles is as described by Zuberek at al. [17].
After next 24 h incubation, the medium was removed and cells were
washed twice with 0.15 cm3 per well of PBS solution. The cells were
then ﬂooded with 0.1 cm3 of neutral red solution (50 µg/cm3 neutral
red in the culture medium). After a 4h incubation at 37 °C in an
atmosphere of 5% CO2 neutral red solution was discarded, the cells
washed twice with 0.15 cm3 PBS and 0.15 cm3 of ﬁxative (50% ethanol,
49% H2O, 1% acetic acid) was added to each well. The plate was shaken
for 15 min and the absorbance was measured at a wavelength of
540 nm using an EnVision® Multilabel Reader (Perkin-Elmer) [23].
2.3. Gene expression analysis
Total RNA was isolated from 106 HepG2 cells employing MagNA
Pure LC 2.0 Instrument (Roche) according to the manufacturer's
protocol. Genomic DNA was removed by DNase I digestion (RNase
free DNase, Life Technologies) and 1 µg of the total RNA was reverse-
transcribed using the SuperScript™ III First-Strand Synthesis
SuperMix (Life Technologies). qPCR analysis was performed with
C1000 Thermal Cycler–CFX96 Real-Time System (BioRad). Primers
were obtained from RealTimePrimers.
2.4. Nitric oxide measurement
Cells for ﬂow cytometry evaluation of nitric oxide were plated on 6-
well plates in density of 167·105 cells/cm3 in 3 cm3 of low or high
glucose DMEM. AgNPs were added after 24 h to ﬁnal concentration of
25 µg/ml for another 24, 48 or 72 h of incubation, after which cells
were trypsinized and resuspended in 1 cm3 of culture medium. DAF-
FM was added to ﬁnal concentration of 5 µM and ﬂuorescence intensity
was recorded in FITC channel (LSRII ﬂow cytometer) after 30 min of
incubation in 37 °C.
2.5. Measurement of reactive oxygen species
Cells for ﬂow cytometry evaluation of nitric oxide were plated on 6-
well plates in density of 167·105 cells/cm3 in 3 cm3 of low or high
glucose DMEM. AgNPs were added after 24 h to ﬁnal concentration of
25 µg/ml for another 4 h of incubation, after which cells were
trypsinized and resuspended in 500 mm3 of full growth media. After
10 min in 37 °C 100 mm3 of DMEM solution of appropriate probe was
added to cell suspension to form ﬁnal concentration of 5 µM for
another 45 min of incubation. Cellular levels of hydrogen peroxide,
cellular superoxide anion and mitochondrial superoxide anion was
measured respectively with DHR123, DHE and MitoSOX.
2.6. Measurement of nitrotyrosine in HepG2 cells
Cell cultures grown in 6-well nunclon delta plates at density of
150,000 cells/cm3 were incubated for 5 min with peroxynitrite in
concentration of 1 mmol/dm3 after 2 h of incubation with AgNPs
(25 µg/ml), after peroxynitrite treatment monolayer was washed twice
with PBS. Cells were lysed and scrapped in RIPA buﬀer immediately
after peroxynitrite incubation and after another 2 or 4 h of incubation
in culture conditions.
2.7. Measurement of nitrotyrosine
Tyrosine in concentration of 1 mmol/dm3 was nitrated with
1.4 mmol/dm3 peroxynitrite in presence of AgNPs in concentration
of 12.5 µg/cm3 or in the presence of BSA in concentration correspond-
ing to one used in preparation of AgNPs suspension. Fluorescent
spectra of tyrosine were obtained at 315 nm excitation wavelength.
3. Results
3.1. Cell survival
Comparison of the eﬀects of AgNPs on cell survival showed that
cells grown in 25 mM glucose and transferred to medium of a lower
glucose concentration (5.5 mM) for 48 h were more resistant than cells
maintained in 25 mM glucose (Fig. 1). This result conﬁrms our
previous observations on the higher toxicity of AgNPS to HepG2 cells
grown on high glucose as compared with cells cultivated on low glucose
for a prolonged time [17].
Fig. 1. Eﬀect of AgNPs treatment on the survival of HepG2. Cells were grown in high
glucose DMEM and transferred to either high glucose DMEM (25 mmol/dm3) or low
glucose DMEM (5.5 mmol/dm3). After 48 h, cells were treated with AgNPs (2.5–50 µg/
cm3). After 24 h of incubation viability was assessed with neutral red method. Curves
were compared with extra sum of square F test and are statistically diﬀerent, p=0.0118,
N=12 (high glucose), N=9 (low glucose).
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3.2. Analysis of gene expression
Lowering glucose concentration in the culture medium increased
the mRNA level for NOS2 and NOS2A. No signiﬁcant changes were
found for NADPH oxidase 5, the main extramitochondrial source of
superoxide radical (Table 1).
3.3. Nitric oxide level
Decrease of glucose concentration from 25 down to 5.5 mol/dm3
lead to stabilization of intracellular nitric oxide concentration at higher
level after 72 h but not at 24 or 48 h (Fig. 2). This level was not
diﬀerent from that found in cells grown on low-glucose medium for a
month or longer. These results demonstrate that a new redox balance is
attained in the cells after 3 days, apparently being an element of
cellular adaptation to augmented oxidative stress caused by lowered
glucose concentration.
Comparison of nitric oxide levels in cells grown on diﬀerent glucose
concentrations revealed that AgNPs did not induce any detectable
increase in nitric oxide in cells grown in 25 mM glucose and even
decreased nitric oxide generation in cells grown in 5.5 mmol/dm3
glucose (Fig. 3).
3.4. Production of reactive oxygen species
Cystosolic superoxide level was considerably lower in cells grown in
high glucose than in cells grown in low glucose. AgNPs did not aﬀect
signiﬁcantly the cytosolic superoxide level in cells grown in both high
and low glucose concentrations (Fig. 4A). Mitochondrial superoxide
level measured with MitoSOX was also lower in cells grown in low
glucose (as compared with cells grown in high glucose); AgNPs
increased superoxide level in cells grown in high glucose while not
aﬀecting superoxide production in cells grown in low glucose (Fig. 4C).
The cellular level of peroxides reﬂected that of mitochondrial super-
oxide (Fig. 4B), conﬁrming that mitochondria were the main source of
cellular peroxides in HepG2 cells.
3.5. Nitrotyrosine level
Endogenous level of protein nitration in HepG2 cells was below the
detection level of the ELISA test used. Protein nitration induced by
exogenous peroxynitrite was higher in cells grown in lowglucose
medium. AgNPs treatment tended to increase the level of protein
nitration in cells grown on high glucose (not reaching statistical
signiﬁcance) and did not aﬀect the level of protein nitration in cells
grown on low glucose. The level of nitrotyrosine decreased during
subsequent incubation, the rate of denitration being lower in cells
grown in 5.5 mM glucose. After 2–4 h the level of nitrotyrosine
dropped down below the detection limit. In cells grown on low glucose,
the rate of nitrotyrosine removal was higher in the presence of AgNPs
(Fig. 5).
Control experiments in which tyrosine nitration was determined
ﬂuorimetrically demonstrated the AgNPs inhibited nitration of tyrosine
(Fig. 6).
4. Discussion
Our previous paper demonstrated that glucose availability can
modulate the toxic action of AgNPs via regulation of levels of proteins
involved in cellular antioxidant defense [17].
We have found an increased activity of mitochondria, responsible
for oxidative phosphorylation, under lowered glucose conditions. This
eﬀect activates signaling pathways controlled by cellular levels of ROS.
We expected that stress induced by lowered glucose will be augmented
by stress induced by nanoparticles. To the contrary, the cells cultured
after prolonged (over one month) under low glucose conditions were
found to be less susceptible to AgNPs than cells grown in 25 mM
glucose. We ascribe this eﬀect to the stimulation of antioxidant defense
in cells stressed by low glucose conditions, as evidenced, i. a., by
increased activities of main antioxidant enzymes [17]. This process of
adaptation requires time and ﬁrst discernible eﬀects can be observed at
48 h after the change of the medium.
Induction of oxidative stress induced by transfer of the cells to
increased glucose concentration has been reported in the literature.
This eﬀect is ascribed to the production of free radicals in the process of
glucose autoxidation. Glucose can enolize and form ROS (superoxide
anion and hydrogen peroxide) even under physiological conditions
[24]. Increased generation of ROS may slow down the rate of cell
proliferation [25]. However, some authors reported induction of ROS
generation by cell transfer to medium containing low glucose concen-
tration. This eﬀect took place already 15–30 min after the lowering of
glucose concentration in the medium and was inhibited by rotenone,
which points to Complex I of the respiratory chain as the main source
of ROS [26].
Table 1
Expression of inducible nitric oxide synthase and NADPH oxidase on mRNA level in
HepG2 cells. Cells were grown on low glucose DMEM for 72 h prior to RNA isolation.
Expression is presented as fold change of expression in cells cultured on low glucose
(5.5 mmol/dm3) relative to cells cultured on high glucose (25 mmol/dm3). Signiﬁcance
was tested via Pair Wise Fixed Reallocation Randomisation Test using REST 2009
software.
Gene Expression 95% C.I. Result
NOS2 27.284 23.721–29.651 UP
NOS2A 25.516 22.534–27.974 UP
NOX5 1.886 0.524–4.254 –
Fig. 2. The eﬀect of high glucose medium on the nitric oxide level in HepG2 cells. The
cells were grown in high glucose medium. Then the cells were transferred either to a low
glucose (5.5 mol/dm3) or high glucose medium (25 mol/dm3). The level of nitric oxide
was determined after 24 h, 48 h and 72 h with 5 µM DAF-FM in a fow cytometer.
Asterisk denotes statistically signiﬁcant diﬀerence (P < 0.05). Bars represent means and
error bars represent SEM.
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Fig. 3. The level of nitric oxide in HepG2 cells treated with AgNPs. The cells were grown
in DMEM medium containing low (5.5 mmol/dm3) or high (25 mmol/dm3) glucose
concentration. The cells were treated with AgNPs (25 µg/cm3) for two hours. Then the
nitric oxide in the cells was estimated with 5 µM DAF-FM in a ﬂow cytometer.r Asterisk
denotes statistically important diﬀerence between cells cultured on low glucose con-
centration (5.5 mmol/dm3) and all other samples (P < 0.05). Bars represent means and
error bars represent SEM.
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In this paper, we used HepG2 as a model cell line. This line adapts
easily to various culture conditions [22]. ATCC recommends culturing
these cells in medium containing 1 g/L of glucose but these cells grow
well in a medium containing 25 mM glucose, and only 50 mM glucose
limits cell survival and induces apoptosis after prolonged incubation
(72 h) [27]. HepG2 cells are derived from hepatocytes, in which glucose
conditions may be high due to glycogenolysis and gluconeogenesis as
these cells produce glucose and release it to the bloodstream so high
glucose conditions may imitate better the in vivo conditions for these
cells [28].
Analysis of survival data and expression of oxidative stress-related
genes [17] allows to conclude that adaptation of HepG2 cells to new
culture conditions requires at least 72 h. A signiﬁcant increase in the
level of transcript coding inducible NOS has been observed not earlier
but after 72 h of culture in lowglucose medium. This enzyme is
responsible for generation of relatively high concentrations of nitric
oxide in the cells. The increased activity of iNOS is maintained during
at least one-month culture of the cells in low glucose (not shown).
Apparently, this stimulation of iNOS expression may be due to
disturbances in the redox balance caused by increased activity of the
mitochondrial respiratory chain.
Transcriptional regulation of the gene responsible for the produc-
tion of iNOS is complex and still not fully understood. Several signaling
cascades have been found to control the expression of iNOS in cells at
the transcriptional level, including JNK/ p38, NF-κB, JAK and STAT
[29]. The iNOS promotor is controlled by numerous transcription
factors, the most important being NF-κB p50: p65. This factor is
activated, i. a., by lipopolysaccharide (LPS), viral products, cytokines,
cell–cell contact, neurotoxins and oxidative stress [6]. The C/EBP
transcription factor, activated by LPS, viral products, CD40 ligation,
cAMP, hypoxia IL-1β, dsRNA, glucose metabolites acts probably as a
co-activator [30]. The STAT-1 transcription factor has been identiﬁed
Fig. 4. Levels of cellular superoxide anion (A), cellular peroxides (B) and mitochondrial superoxide anion (C) measured with DHE, DHR123 and MitoSOX respectively in HepG2 cells
cultured on two diﬀerent concentrations of glucose (H – 25 mmol/dm3, L – 5.5 mmol/dm3) and treated with AgNPs at a concentration of 25 µg/cm3. Bars represent means and error
bars represent SEM. Asterisk in panel A represent statistically signiﬁcant diﬀerence (α=0.05, n=3). Capital letters A in panels B and C denote groups between which we found no
statistically signiﬁcant diﬀerence; otherwise the diﬀerences are statistically signiﬁcant (α=0.05, n=3(B), n=6(C), n=6(D)). Groups in presented experiments were compared with ANOVA
followed by Tukey's post hoc test.
Fig. 5. Nitrotyrosine level in proteins from HepG2 cell lysates cultured in high glucose
(25 mmol/dm3) (A) or low glucose (5.5 mmol/dm3) (B) DMEM. Cell cultures were
incubated for 5 min with peroxynitrite in concentration of 1 mmol/dm3 in 1 cm3 of PBS
solution, after 2 h of incubation with AgNPs (25 µg/cm3). Cells were lysed immediately
after peroxynitrite incubation and after 2 and 4 h. Bars represent means and error bars
represent SEM (n=3), ND stands for not detectable.
Fig. 6. Eﬀect of AgNPs on the nitration of tyrosine (TYR) by peroxynitrite. TYR
(1 mmol/dm3 ﬁnal concentration) in PBS was mixed with peroxynitrite (1.4 mmol/
dm3 ﬁnal concentration) in the presence of AgNPs in concentration 12.5 µg/cm3 or in the
presence of BSA in concentration corresponding to one used in preparation of AgNPs
suspension. Fluorescence spectra (αex=315 nm) of nitrotyrosine were measured in a
EnVision® Multilabel Reader.
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as a negative regulator of the iNOS gene [31,32]. The role of AP1
proteins in the regulation of iNOS promotor is still controversial; it was
found, however, that Fra-1, Fra-2, JunB, JunD, and FosB transcription
factors are involved in the regulation of iNOS expression and NO
production [33,34]. On this basis it can be expected that ROS play a key
role in the regulation of iNOS expression and a disturbance in the
redox balance may lead to an increased NO generation in the cells.
We observed decreased levels of cytoplasmic superoxide and
hydrogen peroxide in cells grown on low glucose upon incubation with
AgNPs (Fig. 4). Increased ROS generation by nanoparticles has been
reported by many authors. However, increased generation of hydrogen
peroxide in cells treated with AgNPs is usually found in high-glucose
media (or precise information on culture conditions is lacking) and the
studies do not consider the endogenous ROS production by mitochon-
dria and its eﬀect on the redox state of the cells.
This eﬀect may not reﬂect the true level of superoxide but to be due
to the lower accessibility of superoxide for the ﬂuorogenic probe.
Superoxide reacts rapidly with NO forming peroxynitrite. This reaction
proceeds at a very high rate and is diﬀusion-controlled (k~1×1010 M–
1 s–1). The reaction rate constant of superoxide with dihydroethidine is
much lower (2.17 ± 0.059×103 M−1 s−1), so in spite of the higher
concentration of the probe with respect to NO, the latter may compete
signiﬁcantly for superoxide, the more that it is constantly produces in
the system [35]. The mitochondrial production of superoxide was
increased in cells grown on low glucose (Fig. 4), which may underlie
this eﬀect. Similarly, the level of NO was decreased in cells grown in
low glucose by treatment of AgNPs. Both these observations are
compatible with the hypothesis that increased consumption of super-
oxide and NO can explain the lower level of superoxide, hydrogen
peroxide and NO found in cells grown on low glucose, inducing higher
iNOS expression. Alternatively, it can be suggested that AgNPs increase
biosynthesis of antioxidant proteins which decompose ROS and inhibit
the activity or attenuate the expression of iNOS, especially under low
glucose conditions.
We found increased protein nitration in cells grown on low glucose
by exogenous peroxynitrite. Nitrotyrosine formation is one of the main
protein modiﬁcations induced by peroxynitrite. The level of protein
nitration by endogenously produced peroxynitrite is low due to the
eﬃcient protection against peroxynitrite and protein denitratase activ-
ity. Indeed, low levels of peroxynitrite could be detoxiﬁed by enzymatic
and nonenzymatic systems [36–39]. In our experiments, no increased
protein nitration by endogenously formed peroxynitrite was found in
cells grown on low glucose. This results is apparently conditioned by
low yield of nitration under physiological and cell culture conditions. It
has been reported that even under inﬂammatory conditions, one to ﬁve
3-nitrotyrosine residues per 10,000 tyrosine residues are detected
[40,41], due mainly to repair mechanisms of the tyrosyl radical such
as reduction by glutathione and to metabolism of 3-nitrotyrosine.
The small fraction of nitrated protein under physiological condi-
tions cast doubt on its possible biological relevance. It is noteworthy to
indicate, however, that a relatively limited number of proteins are
preferential targets of nitration, and within these proteins, only one or
a few speciﬁc tyrosines can be nitrated.
Addition of a –NO2 group to tyrosine lowers the pKa of its phenolic
hydroxyl group by 2–3 units and adds a bulky substituent; if placed on
relevant tyrosines, nitration can alter protein function and conforma-
tion, impose steric restrictions, and also inhibit tyrosine phosphoryla-
tion. However, to have biological signiﬁcance, a loss-of-function
modiﬁcation requires a large fraction of protein to become nitrated
at speciﬁc critical tyrosines and result in 3-nitrotyrosine to tyrosine
ratios in the range of 0.1–1.0; documentation of these large ratios for a
given protein in vivo is scanty, and it is doubtful that many proteins
will undergo such an extent of nitration.
Our study demonstrates eﬀective removal of nitrotyrosine from
cellular proteins nitrated by exogenous peroxynitrite (Fig. 5). In the
work of Aghdam et al. [42] it was shown that activity of proteasome is
directly connected with glucose levels in intracellular environment;
proteasome activity is elevated at higher glucose concentration. Our
research shows that glucose concentration in culture media inﬂuences
the rate of removal of modiﬁed proteins. Higher concentration of
glucose promotes faster degradation of nitrated proteins. AgNPs
increase the rate of degradation at lower glucose concentration due
to oxidative stress [43] activating NRF2 signaling pathway, which in
turn elevates proteasome activity [44].
The presence of a nitoryrosine denitrase activity, independent of
digestion of nitrated proteins, was ﬁrst reported by Kamisaki et al. [45].
According to the present knowledge, denitrase activity can be described
as an oxygen-regulated and endotoxin-induced tissue-speciﬁc process,
detectable in brain, spleen, and lung of LPS-treated rats, in untreated
rat heart and brain as well as in LPS-treated RAW 264.7 cells [46]. The
present strongly suggest that the denitrase activity is present also in
HepG2 cells and is higher in cells grown on high glucose. However,
since we did not use protease inhibitors, it cannot be excluded that the
removal of nitrotyrosine residues is partly dependent on proteolysis of
nitrated proteins.
The in vitro test (Fig. 6) demonstrated that the presence of silver
nanoparticles attenuates nitrotyrosine formation, apparently due to
peroxynitrite decomposition. However, in the cellular system the
presence of AgNPs did not protect cellular proteins against nitration,
in cells grown on low or high glucose. Apparently, more eﬃcient
peroxynitrite-decomposing mechanisms present in the cells make the
role of AgNPs marginal in cellular systems, in contrast to the simple
system of peroxynitrite + tyrosine. The increased de-nitration of
proteins in cells grown on low glucose incubated with AgNPs is
noteworthy. There are no data on denitrase activity of AgNPS and
such a mechanism does not seem probable. Rather, AgNPs can be
expected to induce synthesis of defensive proteins which may include
those showing denitrase activity or proteolytic activity.
Lipid peroxidation can be described as an oxidation of lipids
containing double carbon-carbon bonds leading to formation of per-
oxides. Most susceptible to peroxidation are polyunsaturated fatty
acids (PUFAs), but other lipids like glycolipids, phospholipids (PLs)
and cholesterol can undergo the process as well. Lipids can be oxidized
in enzymatic processes, involving lipoxygenases, cyclooxygenases and
cytochrome P450 and non-enzymatically in a chain process initiated by
free radicals.
Lipid peroxidation was initially studied as a deleterious outcome of
oxidative stress, however the regulatory aspect of the process was also
noticed [47]. Lipid peroxidation is a physiological process proceeding
under physiological conditions but is enhanced in oxidative stress.
Under conditions of mild oxidative stress, lipid peroxidation products
upregulate antioxidant protection system which in turn limits the
harmful eﬀects of oxidative stress. However intensiﬁed lipid peroxida-
tion can lead to cell death by apoptosis, necrosis or autophagy [48–50].
Most extensively studied secondary products of lipid peroxidation are
malondialdehyde (MDA), propanal, hexanal and 4-hydroxynonenal (4-
HNE). MDA and 4-HNE were described respectively as most muta-
genic and most toxic products of lipid peroxidation [51]. 4-HNE is
considered as one of the major lipid peroxidation products and
mediating secondary eﬀects of oxidative stress [52]. High toxicity of
4-HNE is tied with its high reactivity against thiol and amino groups
[53]. It was found that 4-HNE upregulates many transcription factors
e.g. nuclear factor erythroid 2-related factor 2 (Nrf2) [54–56], activat-
ing protein-1 (AP-1) [57], NF-κB [58] and peroxisome-proliferator-
activated receptors (PPAR) [59,60], mitogen-activated protein kinases
(MAPK) and other stress response pathways [61]. Non-physiological
levels of 4-HNE can promote development and progression of patho-
logical states such as neurodegenerative diseases [62], diabetes melli-
tus [63], and carcinogenesis [64,65]. In our previous work [17] we have
shown that change in environment glucose level promotes cell adapta-
tion to oxidative stress. 4-HNE can be one of the key signaling molecule
behind this adaptation process, the more that nanoparticles have been
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demonstrated to promote lipid peroxidation [66].
In summary, AgNPs do not induce nitrative stress in HepG2 cells
but even inhibit nitration in a cell-free system, most probably by
reacting with peroxynitrite (although this eﬀect seems to be of no
importance in cellular systems) and accelerate the de-nitration of
tyrosine residues. Apparently, the action of AgNPs in HepG2 cells is
not direct but mediated by induction of biosynthesis of defensive
proteins, especially in cells grown in low glucose. This question
requires further studies.
References
[1] R. de Lima, A.B. Seabra, N. Duran, Silver nanoparticles: a brief review of
cytotoxicity and genotoxicity of chemically and biogenically synthesized nanopar-
ticles, J. Appl. Toxicol. 32 (11) (2012) 867–879.
[2] M. Ahamed, M.S. Alsalhi, M.K. Siddiqui, Silver nanoparticle applications and
human health, Clin Chim Acta. 411 (23–24) (2010) 1841–1848.
[3] D.P. Jones, Redeﬁning oxidative stress, Antioxid. Redox Signal 8 (9–10) (2006)
1865–1879.
[4] G. Bartosz, Reactive oxygen species: destroyers or messengers?, Biochem Pharm.
77 (8) (2009) 1303–1315.
[5] H.Y. Sohn, et al., Crucial role of local peroxynitrite formation in neutrophil-induced
endothelial cell activation, Cardiovasc Res 57 (3) (2003) 804–815.
[6] B.S. Taylor, et al., Multiple NF-kappaB enhancer elements regulate cytokine
induction of the human inducible nitric oxide synthase gene, J. Biol. Chem. 273
(24) (1998) 15148–15156.
[7] E. McNeill, et al., Regulation of iNOS function and cellular redox state by
macrophage Gch1 reveals speciﬁc requirements for tetrahydrobiopterin in NRF2
activation. Free Radic Biol Med. 79: p. 206–16
[8] L.J. Ignarro, Nitric oxide. A novel signal transduction mechanism for transcellular
communication, Hypertension 16 (5) (1990) 477–483.
[9] S. Cuzzocrea, D. Salvemini, Molecular mechanisms involved in the reciprocal
regulation of cyclooxygenase and nitric oxide synthase enzymes, Kidney Int 71 (4)
(2007) 290–297.
[10] M. Manderscheid, et al., Regulation of inhibitor of apoptosis expression by nitric
oxide and cytokines: relation to apoptosis induction in rat mesangial cells and raw
264.7 macrophages, J. Am. Soc. Nephrol. 12 (6) (2001) 1151–1163.
[11] M. Hermann, A. Flammer, T.F. Luscher, Nitric oxide in hypertension, J. Clin.
Hypertens. (Greenwich) 8 (12 Suppl 4) (2006) 17–29.
[12] T. Nauser, W.H. Koppenol, The rate constant of the reaction of superoxide with
nitrogen monoxide: approaching the diﬀusion limit, J. Phys. Chem. A 106 (16)
(2002) 4084–4086.
[13] C. Szabo, H. Ischiropoulos, R. Radi, Peroxynitrite: biochemistry, pathophysiology
and development of therapeutics, Nat. Rev. Drug Disco. 6 (8) (2007) 662–680.
[14] H. Ischiropoulos, A.B. al-Mehdi, Peroxynitrite-mediated oxidative protein mod-
iﬁcations, FEBS Lett. 364 (3) (1995) 279–282.
[15] G. Bartosz, Peroxynitrite: mediator of the toxic action of nitric oxide, Acta Biochim
Pol. 43 (4) (1996) 645–659.
[16] A. Manke, L. Wang, Y. Rojanasakul, Mechanisms of nanoparticle-induced oxidative
stress and toxicity, Biomed. Res Int (2013) (p. 942916).
[17] M. Zuberek, et al., Glucose availability determines silver nanoparticles toxicity in
HepG2, J Nanobiotechnology. 13 (2015) 72.
[18] E. Cadenas, K.J. Davies, Mitochondrial free radical generation, oxidative stress, and
aging, Free Radic. Biol. Med 29 (3–4) (2000) 222–230.
[19] B.M. Hybertson, Oxidative stress in health and disease: the therapeutic potential of
Nrf2 activation, Mol Aspects Med. 32 (4–6) (2011) 234–246.
[20] M.J. Morgan, Z.G. Liu, Crosstalk of reactive oxygen species and NF-kappaB
signaling, Cell Res. 21 (1) (2011) 103–115.
[21] Y. Son, et al., Mitogen-Activated Protein Kinases and Reactive Oxygen Species: how
Can ROS Activate MAPK Pathways?, J. Signal Transduct. (2011) (p. 792639).
[22] R. Domenis, et al., Glucose-modulated mitochondria adaptation in tumor cells: a
focus on ATP synthase and inhibitor Factor 1, Int. J. Mol Sci. 13 (2) (2012)
1933–1950.
[23] K. Chiba, K. Kawakami, K. Tohyama, Simultaneous evaluation of cell viability by
neutral red, MTT and crystal violet staining assays of the same cells, Toxicol. Vitr.
12 (3) (1998) 251–258.
[24] S.P. Wolﬀ, R.T. Dean, Glucose autoxidation and protein modiﬁcation. The potential
role of 'autoxidative glycosylation' in diabetes, Biochem J. 245 (1) (1987) 243–250.
[25] F. Curcio, A. Ceriello, Decreased cultured endothelial cell proliferation in high
glucose medium is reversed by antioxidants: new insights on the pathophysiological
mechanisms of diabetic vascular complications, Vitr. Cell Dev. Biol. 28A (11–12)
(1992) 787–790.
[26] A. Sarre, et al., Reactive oxygen species are produced at low glucose and contribute
to the activation of AMPK in insulin-secreting cells, Free Radic Biol Med. 52 (1)
(2011) 142–150.
[27] K. Chandrasekaran, et al., Apoptosis in HepG2 cells exposed to high glucose,
Toxicol In Vitro. 24 (2) (2010) 378–396.
[28] K. Chandrasekaran, et al., Increased oxidative stress and toxicity in ADH and
CYP2E1 overexpressing human hepatoma VL-17A cells exposed to high glucose,
Integr Biol (Camb). 45 (5) (2012) 550–563.
[29] R.N. Saha, K. Pahan, Regulation of inducible nitric oxide synthase gene in glial
cells, Antioxid. Redox Signal 8 (5–6) (2006) 929–947.
[30] A.Y. Kolyada, N.E. Madias, Transcriptional regulation of the human iNOS gene by
IL-1beta in endothelial cells, Mol. Med 7 (5) (2001) 329–343.
[31] R.W. Ganster, et al., Complex regulation of human inducible nitric oxide synthase
gene transcription by Stat 1 and NF-kappa B, Proc. Natl. Acad. Sci. USA 98 (15)
(2001) 8638–8643.
[32] W. Eberhardt, et al., Molecular mechanisms of inducible nitric oxide synthase gene
expression by IL-1beta and cAMP in rat mesangial cells, J. Immunol. 160 (10)
(1998) 4961–4969.
[33] A.S. Kristof, J. Marks-Konczalik, J. Moss, Mitogen-activated protein kinases
mediate activator protein-1-dependent human inducible nitric-oxide synthase
promoter activation, J. Biol. Chem. 276 (11) (2001) 8445–8452.
[34] W. Ratajczak-Wrona, et al., Role of AP-1 family proteins in regulation of inducible
nitric oxide synthase (iNOS) in human neutrophils, J. Immunotoxicol. 10 (1)
(2013) 32–39.
[35] M.N. Alvarez, et al., Macrophage-derived peroxynitrite diﬀusion and toxicity to
Trypanosoma cruzi, Arch. Biochem Biophys. 432 (2) (2004) 222–232.
[36] R. Radi, et al., Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of
superoxide and nitric oxide, J. Biol. Chem. 266 (7) (1991) 4244–4250.
[37] M. Trujillo, R. Radi, Peroxynitrite reaction with the reduced and the oxidized forms
of lipoic acid: new insights into the reaction of peroxynitrite with thiols, Arch.
Biochem Biophys. 397 (1) (2002) 91–98.
[38] G.E. Arteel, K. Briviba, H. Sies, Protection against peroxynitrite, FEBS Lett. 445 (2–
3) (1999) 226–230.
[39] R. Bryk, P. Griﬃn, C. Nathan, Peroxynitrite reductase activity of bacterial
peroxiredoxins, Nature 407 (6801) (2000) 211–215.
[40] M.L. Brennan, et al., A tale of two controversies: deﬁning both the role of
peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and
myeloperoxidase-deﬁcient mice, and the nature of peroxidase-generated reactive
nitrogen species, J. Biol. Chem. 277 (20) (2002) 17415–17427.
[41] I.V. Turko, et al., Protein tyrosine nitration in the mitochondria from diabetic
mouse heart. Implications to dysfunctional mitochondria in diabetes, J. Biol. Chem.
278 (36) (2003) 33972–33977.
[42] S.Y. Aghdam, et al., High glucose and diabetes modulate cellular proteasome
function: Implications in the pathogenesis of diabetes complications, Biochem
Biophys Res Commun. 432 (2) (2013) 339–344.
[43] S.J. Kang, et al., Role of the Nrf2-heme oxygenase-1 pathway in silver nanoparticle-
mediated cytotoxicity, Toxicol Appl Pharmacol. 258 (1) (2011) 89–98.
[44] C.T. Aiken, et al., Oxidative stress-mediated regulation of proteasome complexes,
Mol Cell Proteomics. 10 (5) (2011) p. R110 006924.
[45] Y. Kamisaki, et al., An activity in rat tissues that modiﬁes nitrotyrosine-containing
proteins, Proc. Natl. Acad. Sci. USA 95 (20) (1998) 11584–11589.
[46] I. Sadowska-Bartosz, et al., Posttranslational protein modiﬁcations by reactive
nitrogen and chlorine species and strategies for their prevention and elimination,
Free Radic Res. 48 (11) (2014) 1267–1284.
[47] S.J. Chapple, X. Cheng, G.E. Mann, Eﬀects of 4-hydroxynonenal on vascular
endothelial and smooth muscle cell redox signaling and function in health and
disease, Redox Biol. 1 (2013) 319–331.
[48] S.B. Sunjic, et al., The inﬂuence of 4-hydroxy-2-nonenal on proliferation, diﬀer-
entiation and apoptosis of human osteosarcoma cells, Biofactors 24 (1–4) (2005)
141–148.
[49] P. Haberzettl, B.G. Hill, Oxidized lipids activate autophagy in a JNK-dependent
manner by stimulating the endoplasmic reticulum stress response, Redox Biol. 1
(2012) 56–64.
[50] Z.F. Peng, et al., Deciphering the mechanism of HNE-induced apoptosis in cultured
murine cortical neurons: transcriptional responses and cellular pathways,
Neuropharmacology 53 (5) (2007) 687–698.
[51] H. Esterbauer, P. Eckl, A. Ortner, Possible mutagens derived from lipids and lipid
precursors, Mutat. Res 238 (3) (1990) 223–233.
[52] N. Zarkovic, 4-hydroxynonenal as a bioactive marker of pathophysiological
processes, Mol. Asp. Med 24 (4–5) (2003) 281–291.
[53] R.J. Schaur, Basic aspects of the biochemical reactivity of 4-hydroxynonenal, Mol.
Asp. Med 24 (4–5) (2003) 149–159.
[54] R.C. Siow, et al., Cardiovascular targets for estrogens and phytoestrogens:
transcriptional regulation of nitric oxide synthase and antioxidant defense genes,
Free Radic. Biol. Med 42 (7) (2007) 909–925.
[55] M. Tanito, M.P. Agbaga, R.E. Anderson, Upregulation of thioredoxin system via
Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection
in vivo and in vitro, Free Radic. Biol. Med 42 (12) (2007) 1838–1850.
[56] A. Ishikado, et al., Low concentration of 4-hydroxy hexenal increases heme
oxygenase-1 expression through activation of Nrf2 and antioxidative activity in
vascular endothelial cells, Biochem Biophys Res Commun. 402 (1) (2010) 99–104.
[57] S. Camandola, G. Poli, M.P. Mattson, The lipid peroxidation product 4-hydroxy-
2,3-nonenal increases AP-1-binding activity through caspase activation in neurons,
J. Neurochem 74 (1) (2000) 159–168.
[58] S.J. Lee, et al., HNE-induced 5-LO expression is regulated by NF-{kappa}B/ERK
and Sp1/p38 MAPK pathways via EGF receptor in murine macrophages,
Cardiovasc Res. 88 (2) (2010) 352–359.
[59] Z. Wang, et al., 4-Hydroxynonenal diﬀerentially regulates adiponectin gene
expression and secretion via activating PPARgamma and accelerating ubiquitin-
proteasome degradation, Mol Cell Endocrinol. 349 (2) (2011) 222–231.
[60] A. Cerbone, et al., 4-Hydroxynonenal and PPARgamma ligands aﬀect proliferation,
diﬀerentiation, and apoptosis in colon cancer cells, Free Radic. Biol. Med 42 (11)
(2007) 1661–1670.
[61] N. Shibata, et al., 4-Hydroxy-2-nonenal upregulates and phosphorylates cytosolic
phospholipase A(2) in cultured Ra2 microglial cells via MAPK pathways,
Neuropathology. 31 (2) (2011) 122–128.
M. Zuberek et al. Redox Biology 11 (2017) 646–652
651
[62] K. Zarkovic, 4-hydroxynonenal and neurodegenerative diseases, Mol. Asp. Med 24
(4–5) (2003) 293–303.
[63] M. Jaganjac, et al., Reactive aldehydes–second messengers of free radicals in
diabetes mellitus, Free Radic Res. 47 (1) (2013) 39–48.
[64] P. Pettazzoni, et al., Induction of cell cycle arrest and DNA damage by the HDAC
inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-
hydroxynonenal in prostate cancer cells, Free Radic Biol Med. 50 (2) (2010)
313–322.
[65] S. Pizzimenti, et al., The "two-faced" eﬀects of reactive oxygen species and the lipid
peroxidation product 4-hydroxynonenal in the hallmarks of cancer, Cancers
(Basel). 2 (2) (2010) 338–363.
[66] L. Foucaud, et al., Oxidative stress induction by nanoparticles in THP-1 cells with
4-HNE production: stress biomarker or oxidative stress signalling molecule?,
Toxicol In Vitro. 24 (6) (2010) 1512–1520.
M. Zuberek et al. Redox Biology 11 (2017) 646–652
652
Contents lists available at ScienceDirect
Mechanisms of Ageing and Development
journal homepage: www.elsevier.com/locate/mechagedev
Exposure of human neurons to silver nanoparticles induces similar pattern of
ABC transporters gene expression as diﬀerentiation: Study on proliferating
and post-mitotic LUHMES cells
M. Zubereka,⁎, T.M. Stępkowskib, M. Kruszewskib,c,d, A. Grzelaka
aUniversity of Lodz, Faculty of Biology and Environmental Protection, Department of Molecular Biophysics, 141/143 Pomorska St., 90-236, Lodz, Poland
b Institute of Nuclear Chemistry and Technology, 16 Dorodna Str., 03-195, Warsaw, Poland
c Department of Molecular Biology and Translational Research, Institute of Rural Health, Jaczewskiego 2, 20-090, Lublin, Poland
d Faculty of Medicine, University of Information Technology and Management in Rzeszów, ul. Sucharskiego 2, 35-225, Rzeszów, Poland
A R T I C L E I N F O
Keywords:
Silver nanoparticles
Central nervous system
ABC transporter
LUHMES cell line
A B S T R A C T
The Lund human mesencephalic (LUHMES) cell line originated from mesencephalon of 8-week human foetus is a
renowned in vitro model of human dopaminergic neurons. After diﬀerentiation the cells exhibit dopaminergic
and neuronal characteristics of biochemically and morphologically mature dopamine-like neurons. In this study
we analysed expression of 42 genes from ABC transporter superfamily in both proliferating cells and diﬀer-
entiated neurons after treatment with silver nanoparticles. ABC transporter superfamily is especially known due
to the involvement in multidrug resistance phenomenon, but also involvement in transport through blood-brain
barrier. Our results indicate that in neurons silver nanoparticles mainly attenuate transporters responsible for
maintaining asymmetry of cellular membrane and homeostasis of lipids and cholesterol. Our results revealed
also that proliferating foetal brain cells are by far more susceptible to silver nanoparticles than diﬀerentiated
neurons.
1. Background
ABC transporters are highly conserved, ubiquitous proteins, most of
which are transmembrane molecules. The majority of proteins in this
family consist of at least one nucleotide binding domain (NBD) and one
transmembrane domain (TMD). Full transporters consist of two of each,
half transporters have one NBD and one TMD and they must homo- or
heterodimerize to be biologically functional (Dean et al., 2001; Higgins,
1992). They use the energy of ATP hydrolysis to translocate a broad
spectrum of compounds across the cellular and intracellular mem-
branes, including but not limited to inorganic anions, metal ions, pep-
tides, amino acids and sugars (Slot et al., 2011). However, the function
of these proteins is not limited to the transport through membranes, e.g.
proteins of ABCA subfamily are involved in apoptosis signalling
pathway by presenting speciﬁc lipids on the outer plasma membrane
(Aye et al., 2009), while members of subfamilies lacking TMD (ABCE
and ABCF) lack of transport function and play important roles in
translation (Kerr, 2004; Tyzack et al., 2000). In mammals, ABC trans-
porters are expressed predominantly in the liver, intestine, blood-brain
barrier, blood-testis barrier, placenta and kidney but their expression
was also conﬁrmed in neurons.
Presence of particular ABC proteins is closely tied with function of
given cells. Neurons and oligodendrocytes express transporters in-
volved in translocation of lipids (Schmitz and Kaminski, 2002; Tanaka
et al., 2003), glutamate (Domercq et al., 1999; Kanai and Hediger,
2003) and amino acids (Braissant et al., 2001; Mackenzie and Erickson,
2004). In addition, expression of ABCC1 (MRP1) transporter was found
on membranes of microglia and astrocytes (Dallas et al., 2003; Decleves
et al., 2000), the cells associated with loss of neurons during the de-
velopment of neurodegenerative diseases (Nagele et al., 2004;
Teismann and Schulz, 2004). Both are responsible for apoptosis of
neurons in response to oxidative stress and inﬂammation, and are a
therapeutic target in treatment of neurodegenerative diseases
(Kitamura and Nomura, 2003; Liu and Hong, 2003; Monsonego and
Weiner, 2003). Sultana and Butterﬁeld found elevated expression of
ABCC1 (MRP1) proteins in frozen hippocampal samples from patients
suﬀering from Alzheimer’s disease as compared with aged male subjects
without neurodegenerative changes (Sultana and Butterﬁeld, 2004).
Recently, also the activity of other ABC transporters was tied to the
development and progression of Parkinson and Alzheimer diseases
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Though, many aspects of the aetiology of neurodegenerative dis-
orders still need clariﬁcation, ethical issues and implementation of 3R
rule in animal care that limits the use of animals and primary cells in
biological research, make such investigation diﬃcult. Thus, there is an
increasing interest in the in vitro cellular models, mimicking CNS
functions. So far, cancer neuronal cells, such as human neuroblastoma
cell lines (SH-SY5Y or BE2-M17) or rat pheochromocytoma PC12 cells,
are the most commonly studied in vitro models of neuron-like cells.
However, due to their cancer origin, these cells are to a large extent
diﬀerent in the phenotype from mature post-mitotic neurons and need
to be transcriptionally reprogrammed by addition of diverse factors into
the culture media, such as NGF or retinoic acid. As an alternative, the
Lund human mesencephalic (LUHMES) cells were generated to be used
for neuronal transplantation in Parkinson’s disease (Lotharius et al.,
2002; Lotharius et al., 2005). As the LUHMES cells properties closely
resembles those of dopaminergic neurons in vivo, this model can serve
for basic research on processes associated with neurodegenerative dis-
eases, but also as a screening system within neurotoxicological testing
programs. However, whereas, the general neuronal characteristics and
diﬀerentiation status of LUHMES cells at diﬀerent culture conditions
was already elaborated (Paul et al., 2007; Schildknecht et al., 2009),
their comprehensive characterization still await for completion. In-
creased body of evidence points to the detrimental role of nanomater-
ials in the functionality of CNS (Czajka et al., 2015) and their possible
role in neurodegenerative diseases aetiology (Mushtaq et al., 2015).
Nanomaterials in general and silver nanoparticles in particular are
widely used in industry and exposure of humans and other organisms
towards them grows in time. Nevertheless, the questions rose in last
decade on impact of nanomaterials on human health are still un-
answered (Manke et al., 2013). It has been shown that nanoparticles
can penetrate blood-brain barrier (Oberdorster et al., 2004) and accu-
mulate in nervous and liver tissues (Dziendzikowska et al., 2012; Geiser
and Kreyling, 2010). Inside the cells nanoparticles inﬂuence variety of
cellular structures, inter alia, the mitochondria. One of the major eﬀects
of damaging mitochondria is the increase in production of reactive
oxygen species that can further damage cell structures and cause the
cascade of activation of intracellular signalling, including NF-κB, Ap-1,
MAPK, PTP and ERK pathways (Bartlomiejczyk et al., 2013; Manke
et al., 2013). Activation of signalling pathways can lead to changes in
expression of ABC transporters, in particular those involved in response
to oxidative stress. Moreover, reorganization of cellular membrane in
eﬀect of endocytosis of nanoparticles can cause changes in activity of
ABC transporters tied with cellular membrane.
A ubiquitous presence of ABC transporters across variety of cells in
CNS infers their important role in CNS functionality, but also rises
question of its role in the detrimental eﬀects of nanomaterials observed
in the CNS. Nanomaterials are known to penetrate the brain-blood
barrier and placental barrier, but their interaction with ABC transpor-
ters in diﬀerentiated and developing brain is still obscure. Thus, the aim
of this study was to investigate the eﬀect of silver nanoparticles on
expression of several ABC-transporter proteins in diﬀerentiated and
proliferating LUHMES cells and to compare the changes induced by
AgNPs with those observed during diﬀerentiation. However, since dif-
ferentiation of the LUHMES cells is induced by addition of tetracycline,
an antibiotic that blocks protein synthesis, in this study we focused only
on changes in mRNA level.
2. Materials and methods
2.1. Cell culture
LUHMES cells were grown in monolayer in NunclonD™ cell culture
ﬂasks coated with poly-L-ornithine (50 μg/cm3) and human plasma ﬁ-
bronectin (1 μg/cm3) (Sigma-Aldrich) as described in our previous
study (Stepkowski et al., 2016). Diﬀerentiation was conducted
according to the previously established two-step protocol (Scholz et al.,
2011). Detailed description of LUHMES cells culture and diﬀerentiation
can be found in supplementary materials.
2.2. AgNP preparation, characterization and treatment
The stock suspension (2mg/cm3) of the AgNPs of a 20 nm nominal
diameter (PlasmaChem, Germany) was prepared as previously de-
scribed (Kruszewski et al., 2013). In brief, bulk AgNPs were triturated
in agate mortar, then 2mg of NPs was suspended in 800mm3 of water.
Suspension was sonicated (4.2 kJ/cm3) with OmniRuptor 4000 and
then 100mm3 of 15% albumin which was followed by addition of
100mm3 of tenfold concentrated PBS (1.37M NaCl, 27 mM KCl, 80mM
Na2HPO4, 20mM KH2PO4). A detailed characterization of this batch of
AgNPs, including diﬀerent preparation protocols, dispersion, aggrega-
tion and stability in diﬀerent culture media, as well as silver ion release,
was previously described (Kruszewski et al., 2013). A pre- and post-
mitotic (diﬀerentiated) cells grown in 25 cm2 ﬂasks were treated with
vehicle (BSA+PBS) or AgNPs stock solution dispersed in the 4 cm3 of
culture medium to the ﬁnal concentration of 2 μg [AgNPs]/cm3
[medium] for 6 h.
2.3. RNA isolation and cDNA synthesis
Total RNA was extracted from cell pellets quick-frozen in liquid
nitrogen, with the use of ReliaPrep™ RNA Cell and Tissue Miniprep
System according to the manufacturer protocol (Promega). RNA in-
tegration and concentration was assessed by gel electrophoresis and in
Quantus Fluorometer (Promega), respectively. cDNA was synthesized
with GoScript cDNA synthesis kit with the use of a mixture of OligodT
and random primers according to the manufacturer protocol
(Promega). DNA polymerase was heat inactivated for 15min at 70 °C.
2.4. Gene expression studies
Gene expression of ABC family of proteins was assessed with com-
mercially available panel of prevalidated qPCR assays for gene ex-
pression proﬁling of human genes − ABC Transporter Panel, 96
(Roche, Cat. No. 05 339 324 001). Experimental procedures were
conducted accordingly to manufacturers guidelines.
Signiﬁcance was tested via Pair Wise Fixed Reallocation
Randomization Test using REST 2009 software (Pfaﬄ et al., 2002).
Treated samples and control samples were seeded, collected and pro-
cessed in three independent experiments.
3. Results
Expression of 32 genes coding ABC transporter proteins belonging
to the ABCA, ABCB, ABCC, ABCD, ABCE and ABCF families was studied
in relation to cells diﬀerentiation status and silver nanoparticle treat-
ment. A detailed list of genes studied in this research including changes
in their expression is presented in Supplementary materials
(Supplementary Table S1). Here we discuss only genes whose tran-
scription changed signiﬁcantly.
Our results indicate that diﬀerentiation process induces a dramatic
change in expression of mRNA of all tested genes belonging to ABCA
and several genes belonging to ABCC: ABCC5, ABCC8, ABCC10,
ABCC11. A marked change in expression was also observed in case of
ABCB9, ABCD1, ABCD4, ABCF3 genes. Once cells diﬀerentiated, they
lost expression of ABCB4, but started to express ABCA6 and ABCG4,
ABCG5 and ABCG6 genes (Fig. 1). Since tetracycline was used to dif-
ferentiate the LUHMES cells, the question arose whether this treatment
would not stimulate expression of mammalian multidrug resistance
proteins, namely ABCB1 (MDR1), ABCC1 (MRP1), ABCC2 (MRP2),
ABCC3 (MRP3), ABCC4 (MRP4), ABCC5 (MRP5) and ABCG2 (BCRP)
(Schinkel and Jonker, 2003). Comparison of ABC transporters mRNA
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levels in proliferating and diﬀerentiated (tetracycline treated) cells re-
vealed that although expression of ABCB1, ABCC5 was stimulated after
addition of tetracycline, these changes were not signiﬁcant statistically.
The only statistically signiﬁcant change in expression of multidrug re-
sistance proteins observed by us after tetracycline addition was down-
regulation of ABCG2 protein mRNA.
A non-diﬀerentiated cells are far more susceptible to silver nano-
particles treatment than the post-mitotic ones in terms of change of ABC
transporters genes expression. The major changes were observed in
mRNA levels for ABC proteins crucial in cholesterol transport, stabili-
zation of membrane asymmetry and those regulated by oxidative stress,
including (Fig. 2). Interestingly, treatment with AgNPs induced changes
in ABC transporters genes expression very similar to those observed
during diﬀerentiation process, however to the lesser extent (Figs. 1 and
2). Since tetracycline was used to diﬀerentiate the LUHMES cells, the
another question arose whether this treatment would not induce a
oxidative stress similar to this induced by silver nanoparticles, thus
observed similarities result from similar mode of action of both com-
pounds. However, literature survey revealed that this was not the case,
as tetracycline was shown to scavenge free radicals (especially hydroxyl
radical) rather than generate oxidative stress, in cells and in vitro
(Miyachi et al., 1986).
Below changes in gene expression are discussed in detail in regards
to their aﬃnity and putative role.
4. Discussion
There is increasing body of evidence that among many other eﬀects
on living organisms nanomaterials may inﬂuence protein expression,
both on transcriptional (mRNA) and translational (protein) levels
(Matysiak et al., 2016). AgNPs exposure induced expression of oxida-
tive stress response genes (superoxide dismutase 2, glutathione re-
ductase 1, etc.) in mouse brain (Rahman et al., 2009). AgNPs were also
reported to induce changes in mRNA levels of inﬂammatory and neu-
rodegenerative responses in mouse brain neural cells (Huang et al.,
2015). Here we describe the eﬀects of silver nanoparticles on expres-
sion of ABC transporters genes in human neurons in culture. The major
changes were observed in expression of ABCA and ABCC transporter
families gene, thus these genes will be described in details.
4.1. Transporters of ABCA subfamily
ABCA1 is a transporter involved in formation of high density lipo-
proteins (HDLs) and plays a crucial role in sustaining proper cholesterol
metabolism (Oram and Lawn, 2001). During diﬀerentiation, astrocytes
and neurons produce cholesterol, which is essential in the formation of
myelin. Along with the progress of diﬀerentiation biosynthesis of cho-
lesterol slows down, nevertheless, even in the mature neurons choles-
terol is still indispensable in terms of maintaining vital functions and
normal ﬂuidity of cell membrane (Vitali et al., 2016). It has been es-
timated that approximately 25% of the cholesterol is held in the brain
and nervous system, indicating a remarkable role of this molecule in
Fig. 1. Shift of ABC transporters expression proﬁle in LUHMES cells after diﬀerentiation process. Numbers in rectangles represent fold-change in expression of given protein on mRNA
level. Location of the rectangles corresponds to the location of mature proteins. ABC family transporters are grouped colour-wise, while intensity corresponds to magnitude of fold-change
in expression. Statistically signiﬁcant changes were found for ABCA4, ABCA5, ABCA7, ABCB9, ABC11 and ABCG2.
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maintaining homeostasis of nervous system cells. The key role of
ABCA1 in lipid metabolism was conﬁrmed by studies on cell lines. In
vitro studies implicated the role ABCA1 in the eﬄux of cholesterol and
phospholipids from cells to lipid-poor apolipoprotein A1 (apoA-1) to
generate nascent HDL, a pathway termed reverse cholesterol transport.
In CNS ABCA1 regulates transport of cholesterol and phospholipids
thereby facilitating lipidation of ApoE, which is a major apoprotein in
the brain (Hirsch-Reinshagen et al., 2004; Panzenboeck et al., 2002). In
consequence, ABCA1-deﬁciency results in lowered lipidation of ApoE
and in overall decrease of ApoE levels in the brain (Hirsch-Reinshagen
et al., 2004; Wahrle et al., 2004). RT-PCR based studies revealed that
neurons express predominantly ABCA1 and ABCA3 mRNA; astrocytes
express ABCA1, ABCA2 and ABCA3 mRNA; microglia express ABCA1
mRNA and oligodendrocytes express ABCA2 and ABCA3 mRNA (Kim
et al., 2006). In this study expression of ABCA1 increases during dif-
ferentiation. Interestingly also treatment of proliferating cells with
silver nanoparticles also increases the level of ABCA1 mRNA (Fig. 2).
We associate this phenomenon with disturbed membrane architecture
caused by endocytosis of nanoparticles (Fig. 3). A consequence of in-
creased endocytosis is the return of the membrane of the lysosomes to
plasma membrane and ER and enhanced ABCA1 turnover (Cooper,
2000). Increased level of ABCA1 mRNA might be a compensation
mechanism to keep the protein on the necessary level.
Moreover, endosomal ABCA1 protein may facilitate ejection of
cholesterol from endosomes. A liberated cholesterol particles are likely
oxidized by AgNPs derived ROS to oxysterols that in turn stimulate
ABCA1 expression through a Liver X receptor (LXR) transcription factor
(Fig. 3). LXRs are directly involved in regulation of transcription of
ApoE and ABC transporters responsible for normal lipid composition of
ApoE, such as ABCA1 and ABCG1 (Wang et al., 2014). Normal levels of
cholesterol, both in cytosol and cell membrane guarantees the proper
functioning of nerve cells, whereas any disturbances in distribution of
lipids, are linked with many diseases, e.g. Alzheimer disease and
Huntington disease (Markianos et al., 2008).
ABCA4 transporter plays important role in proper functioning of
retinal photoreceptors. In retinal photoreceptor cells it actively ﬂips N-
retinylidene-phosphatidylethanolamine from the lumen to the cyto-
plasmic leaﬂet of disc membranes, and transport of phosphatidyletha-
nolamine in the same direction (Quazi et al., 2012). However, ABCA4
activity is also associated with lowering of oxidative stress. In tissues of
ABCA4(-/-) mice mRNA levels for antioxidative enzymes were in-
creased, whereas the levels of oxidized proteins and lipids were in-
creased when compared to WT mice (Radu et al., 2011). Promoter re-
gion of ABCA4 gene consists of binding sites for oxidative stress
Fig. 2. Change in mRNA levels for ABC transporters in LUHMES cells subjected to 20 nm AgNP (6 h, 2 μg/cm3) treatment before (A) or after (B) diﬀerentiation. Numbers represent fold-
change in expression of given protein on mRNA level after AgNP treatment. Location of the rectangles corresponds to the location of mature proteins. ABC transporters belonging to the
same protein family are grouped colour-wise, while colour intensity corresponds to the magnitude of change in expression. Statistically signiﬁcant changes were found in expression of
ABCA1, ABCA4, ABCA7, ABCB4, ABCB6, ABCB9, ABCC2, ABCC6, ABCC9 and TNFAIP2 for proliferating cells and in expression of ABCD3 for diﬀerentiated cells.
M. Zuberek et al. Mechanisms of Ageing and Development xxx (xxxx) xxx–xxx
4
inducible transcription factors, such as STAT1, NF-κB. Since AgNPs
were shown to strongly induce both NF-κB and JAK-STAT signalling
pathways (Xu et al., 2012) (Stepkowski et al., 2014), and the pathway is
also activated during embryonal stem cells neuronal diﬀerentiation
(Wei et al., 2014), increased expression of ABCA4 mRNA during dif-
ferentiation and after AgNPs treatment could indicate the prior acti-
vation of NF-κB or JAK-STAT1 pathways, which is essential in reg-
ulating the stress response.
ABCA7 is a protein widely expressed in the brain, lung, myelo-
lymphatic tissues, kidneys, macrophages and platelets and it shows
54% similarity with the ABCA1 (Kim et al., 2006). It is postulated, that
both proteins might share the substrate speciﬁcity and function (Abe-
Dohmae et al., 2006). However, some studies indicate that ABCA7 is
responsible for eﬄux of phosphatidylcholine and sphingomyelin rather
than cholesterol (Wang et al., 2003). ABCA7 is intensively studied
protein due to its connection with Alzheimer’s disease, as an absence of
ABCA7 results in reduced ability of macrophages to phagocytose Aβ
and accumulation of insoluble Aβ in brain (Li et al., 2015). ABCA7
promoter region contains binding sites for E47 and TAL-1 transcription
factors. Phosphorylation of E47 is regulated by p38 MAP-Kinases
pathway (Cuenda and Rousseau, 2007) that in turn is activated by
oxidative stress generated by AgNPs. Activation of p38 MAPK was
proposed as a mechanism of toxicity of silver nanoparticles in Jurkat T
cells (Eom and Choi, 2010). On the other hand, activity of the tran-
scription factor TAL-1 is linked with activation of the EGFR pathway
(Zhou et al., 2014) that is also associated with oxidative stress (Wang
et al., 2000). Given that it is possible that silver nanoparticle generated
oxidative stress activate the above mentioned signalling pathways, and
in consequence regulate the mRNA levels of ABCA7 gene.
The expression of ABCA subfamily genes was the most aﬀected by
silver nanoparticles among studied transporters. This demonstrates the
intense disorder of cholesterol metabolism caused by silver nano-
particles and signiﬁcant interference with dynamics of cell membrane.
Nanoparticles have the ability to cross the placenta (Chu et al., 2016;
Kulvietis et al., 2016) and it was found that exposure of laboratory
animals to nanoparticles resulted in changes in foetus expression proﬁle
of genes associated with brain development, cell death, oxidative stress
and inﬂammation (Shimizu et al., 2009). Observations collected during
experiments on laboratory animals in conjunction with ours results
indicate that nanoparticles can signiﬁcantly inﬂuence diﬀerentiating
nerve cells in human foetuses.
4.2. Transporters of ABCB subfamily
ABCB family proteins form elements of blood – brain barrier in
endothelial cells. Diﬀerentiation of LUHMES cells induced a marked
increase in expression of ABCB1 and ABCB9 mRNA. Associated with
outer membrane ABCB1 protein is usually considered in the context of
multi-drug resistance in CNS and in tumour cells. In contrary, ABCB9
transporter seems to be bound to lysosomes, although its exact locali-
zation is still unclear (Demirel et al., 2007). ABCB1 protein is expressed
on the surface of human neural stem/progenitor cells, but its expression
decreases during cell diﬀerentiation to astrocytes (Islam et al., 2005)
whereas ABCB9 expression has been found to increase during the dif-
ferentiation of monocytes into dendritic cells (Demirel et al., 2007).
Here we showed that during diﬀerentiation to dopaminergic neuron
expression of ABCB1 and ABCB9 genes is sustained. Expression of
ABCB1 is also regulated by oxidative stress. Hydrogen peroxide acti-
vates signalling through ERK1/2, PKC, Akt, c-Jun and NFκB, which
turns on ABCB1 transcription (Nwaozuzu et al., 2003). Increased pro-
duction of oxygen free radicals is induced by toxins and nanomaterials
and is associated with many CNS diseases. In capillaries isolated from
rat brains fuel nanoparticles induced increase in expression and activity
of ABCB1 and increase in NADPH activity (Hartz et al., 2008). Oxida-
tive stress is closely tied to CNS diseases by ability to activate TNF-
alpha, TNF-R1, JNK and c-Jun dependent signalling pathways. Thus, it
is likely that silver nanoparticles induced oxidative stress also stimu-
lates transcription of ABCB1 and ABCB9 mRNA.
Treatment of non-diﬀerentiated cells with AgNPs also induced ex-
pression of ABCB4, ABCB6, ABCB7 genes. Although the presence of
mRNA for ABCB4, ABCB6, ABCB7, ABCB8 and ABCB10 has been de-
monstrated in brain homogenates (Warren et al., 2009) and ABCB4 and
ABCB11 (bile salt export pump, BSEP) mRNA has been detected in
human and rat choroid plexus (Choudhuri et al., 2003; Niehof and
Borlak, 2009), there are no evidence however for expression of genes
ABCB2-11 on protein level in CNS. There is also little information
available on expression of these genes in particular kind of brain cells,
including neurons.
ABCB4 is involved in metabolic pathway of bile secretion and reg-
ulation of lipid metabolism by peroxisome proliferator-activated
Fig. 3. Migration and function of ABCA1 in cells treated with silver nanoparticles.
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receptor alpha. The main physiological role on cellular level of ABCB4
is the maintenance of correct lipid composition of both non-raft mem-
branes and membrane rafts (Morita et al., 2013). ABCB6 transporter is
commonly found in mammalian cells. The level of mRNA for this pro-
tein increases during hepatocarcinogenesis (Furuya et al., 1997; Hirsch-
Ernst et al., 1998). ABCB6 localizes in mitochondria and plays a key
role in heme biosynthesis (Crawford et al., 1997). Regulation of ABCB6
expression is complex issue. One of the major signalling pathways in-
ﬂuencing ABCB6 expression is NRF1 pathway, which is closely tied
with regulation of genes expression associated with biogenesis and
correct functioning of mitochondria (Scarpulla, 2002). This suggest that
ABCB6 is expressed strongly in rapidly proliferating cells with need for
rapid synthesis of mitochondrial proteins.
Here we showed that human proliferating neural cells are capable
for expression of ABCB4, ABCB6, ABCB7, ABCB9 genes. Weather this
mRNA is translated into proteins or degraded needs further investiga-
tion. Here we showed that human proliferating neural cells are capable
for expression of ABCB4, ABCB6, ABCB7, ABCB9 genes. Weather this
mRNA is translated into proteins or degraded needs further investiga-
tion. Moreover, we found that mRNA levels for several members of
ABCB subfamily increased after AgNP treatment (Fig. 2), thus implying
a possible role of oxidative stress in regulation of its expression. Indeed,
promoter region of ABCB6 gene contains a putative binding sites for
AP-1 and NFkB transcription factors (see GeneCards Database
ID:GC02M220075). Moreover, CHiP-sequencing revealed that in iso-
thiocyanate sulforaphane treated cells ABCB6 gene is also bound by
NRF2 transcription factor (Campbell et al., 2013).
4.3. Transporters of ABCC subfamily
The ABCC1, ABCC4 and ABCC5 proteins were clearly localized in
brain capillary endothelial cells (Nies et al., 2004), the ABCC3, ABCC4
and ABCC5 proteins were also detected in astrocytes (Hirrlinger et al.,
2002; Hirrlinger et al., 2005; Nies et al., 2004), whereas ABCC5 protein
was present in pyramidal neurons (Nies et al., 2004), with ABCC1 and
ABCC5 being most predominant in brain cells among ABCC family.
ABCC1 was the ﬁrst C protein discovered in CNS (Regina et al., 1998),
and was extensively studied over the years mainly due to its role in
multidrug resistance phenomena. ABCC1 regulation is tied to oxidative
stress responsive signaling pathway, such as MAPK, JNK/STAT and
NFκB (Ronaldson et al., 2016). Indeed, in our study we observed sig-
niﬁcant increase in the level of ABCC1 mRNA in proliferating cells
treated with silver nanoparticle. Interestingly, upregulation of ABCC1
gene expression was negligible either in diﬀerentiated cells treated with
AgNPs or during diﬀerentiation. We have also observed strong increase
in the level of ABCC2, ABCC6 and ABCC9 mRNA. ABCC2 has been
detected in the blood-brain barrier. It was reported that exposure of
capillaries isolated from rat brain to the pregnenolone-16α-carbonitrile
and dexamethasone causes increased activity and expression of ABCC2
(Bauer et al., 2008). In cultured endothelial cells derived from rat brain
capillary dexamethasone caused upregulation of ABCC2 mRNA and
protein in glucocorticoid receptor activation independent manner
(Narang et al., 2008). ABCC9 transcript SUR2 is expressed in variety of
tissues, including brain. On cellular level it regulates function of K+
channels and it is linked, on organismal level, to hippocampal sclerosis
of aging (Nelson et al., 2015). Potassium channels can be regulated in
ROS-dependant manner(Crawford et al., 2003), observed upregulation
after AgNPs treatment suggest that oxidative stress dependant pathway
might be involved in tuning of expression of these proteins.
4.4. Transporters of ABCD subfamily
Member proteins of ABCD transporter subfamily are located in the
peroxisomal membrane, where they transport fatty acids into peroxi-
somes for metabolic breakdown (Theodoulou et al., 2006). The pre-
sence of ABCD1-4 mRNAs was conﬁrmed in mouse brain capillary
endothelial cells, but only ABCD1 was detected on the protein level
(Berger et al., 1999). ABCD1 was also found in astrocytes, microglia and
oligodendrocytes from mouse brain and post-mortem human brain
sections (Fouquet et al., 1997). ABCD3 is one of the peroxisomal
membrane proteins, detected in abundance in hepatocytes and was
reported to transport various fatty acids. Overexpression of the ABCD2
or ABCD3 gene can reverse the biochemical phenotype of X-ALD (re-
duced beta-oxidation of very-long-chain fatty acids) (Fourcade et al.,
2001). ABCD3 along with ABCD2 was show to being upregulated to
compensate the lack of ABCD1 after treatment of astrocytes and oli-
godendrocytes with histone deacetylase inhibitor.
There is no literature on the mechanisms of regulation of expression
of ABCD subfamily genes. Again our results imply oxidative stress in-
volvement in this regulation.
4.5. Transporters of ABCG subfamily
Similarly, little is known about regulation of expression and the role
in CNS of proteins belonging to ABCG family. Wang et al. (Wang et al.,
2008) proposed that proteins of this family function as a of cholesterol,
sterols an sterol complexes transporters. In addition, ABCG2 is an ele-
ment of multidrug resistance maintenance of integrity of the blood-
brain barrier. However, after addition of tetracycline (to diﬀerentiate
the LUHMES cells) we observed downregulation of ABCG2 gene ex-
pression, thus it seems that in line with neural stem cells (Islam et al.,
2005), in neurons ABCG2 is likely responsible for detoxiﬁcation of
xenobiotics. A putative role of ABCG in our experimental setup is reg-
ulation of cholesterol homeostasis. It is supported by the fact that we
detect mRNA for those proteins only in diﬀerentiated cells, where de
novo synthesis of sterols is hindered in comparison to undiﬀerentiated
cells.
5. Summary
In this work we compared ABC transporters mRNA levels in pro-
liferating and non-proliferating human neuronal LUHMES cells native
and treated with silver nanoparticles. Our results indicate that diﬀer-
entiation induced marked changes in expression of several genes coding
proteins belonging to ABC transporter protein family. Interestingly, in
rapidly proliferating cells silver nanoparticles treatment induced si-
milar changes in ABC transporters gene expression as diﬀerentiation.
On the contrary, changes in ABC transporters mRNA level after silver
nanoparticles treatment in post-mitotic cells were much less pro-
nounced that may indicate similarities in cellular signalling pathways
stimulated by diﬀerentiation and silver nanoparticle treatment.
Although we were unable to conﬁrm our results at protein level due to
the unavailability of antibodies against several crucial ABC proteins,
our results point to the possible new impact of silver nanoparticles on
human health, especially on developing brain. Nevertheless, it must be
noted that posttranscriptional and posttranslational regulatory me-
chanisms may aﬀect the ﬁnal expression of ABC transporters at the
protein level, and may modify the eﬀects of silver nanoparticles treat-
ment observed at the transcriptional level.
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